Food and Indoor Air Isolated Bacillus Non-Protein Toxins : Structures, Physico-Chemical Properties and Mechanisms of Effects on Eukaryotic Cells by Mikkola, Raimo
Division of Microbiology 
Department of Applied Chemistry and Microbiology 
Faculty of Agriculture and Forestry
University of Helsinki
Food and Indoor Air Isolated Bacillus Non-Protein
Toxins: Structures, Physico-Chemical Properties 
and Mechanisms of Effects on Eukaryotic Cells 
Raimo Mikkola 
Academic dissertations in Microbiology
To be presented, with the permission of the Faculty of Agriculture and Forestry of the 
University of Helsinki, for public criticism in Auditorium 2402 at Viikki Biocenter, 
Viikinkaari 1, Helsinki, on December 8th., 2006, at 12 o’clock noon. 
Helsinki 2006 
2
Supervisor: Prof. Dr. Mirja Salkinoja-Salonen 
                   Department of Applied Chemistry and Microbiology 
                   Faculty of Agriculture and Forestry 
                   University of Helsinki 
                   Helsinki, Finland 
Reviewers: Prof. Dr. Risto Kostiainen 
                   Division of Pharmaceutical Chemistry
                   Faculty of Pharmacy 
                   University of Helsinki
                   Helsinki, Finland 
                   Prof. Dr. Kimmo Peltonen 
                   Chemistry and Toxicology Unit
                   Department of Animal Diseases and Food Safety Research 
                   Finnish Food Safety Authority Evira 
                   Helsinki, Finland 
Opponent: Prof. Dr. Elke Dittmann 
                  Department of Molecular Ecology
                  Institute of Biology 
                  Humboldt University Berlin 
                  Berlin, Germany
Yliopistopaino
Helsinki, Finland 2006 
ISSN 1795-7079 
ISBN 952-10-3549-8 (paperback)
ISBN 952-10-3550-1 (PDF) 
3
Contents
List of original publications    6 
Abbreviations     7 
Abstract      8 
1. Introduction     10 
1.1. Microbes and toxic metabolites contaminating food   10 
1.2. Microbes and toxic metabolites in moisture-damaged 
 buildings     13 
1.3. Overview of the industrial applications of Bacillus species  15 
1.4. Properties and biological effects of non-protein toxins from the
 genus Bacillus      16
1.4.1. Lipopeptides    26 
1.4.1.1. Lipopeptides of the surfactin family  26 
1.4.1.2. Lipopeptides of the iturin family  28 
1.4.1.3. Fengycins and various lipopeptides  30 
1.4.2. Miscellaneous Bacillus toxins   31 
1.4.3. Cyclic depsipeptides    33 
1.5 Ionophores impair mitochondrial functions   35 
1.5.1. Mitochondrial inner membrane functions  35 
1.5.2. Ionophores have different effects on the mitochondria, 
 impairing their functions    36 
1.6. Synergistic effects of Bacillus toxins   38 
2. Aims of the present study        39  
3. Materials and methods     40 
3.1. Origins of the toxic Bacillus strains   40
3.2. Evaluation of the toxicity of the Bacillus strains using eukaryotic cells 40 
3.3. Purification of the toxins    40 
4
3.4. BLM     41 
4. Results and discussion     44 
4.1. Tolerance towards heat, varied pH, and protease of the toxins 44 
4.2. Purifications of the toxins    45 
4.2.1. Development of the extraction method for the heat-stable Bacillus
  toxins     45 
4.2.2. Purification and quantitation of toxins by RP-HPLC  46 
4.3. Hydrophobicity of the heat-stable toxins isolated from Bacillus 47 
4.3.1. Significance of hydrophobicity     47 
4.3.2. Methods used for assessment of log Kow 48
4.3.3. Log Kow values of the toxins   48  
4.4. Amino acid analysis of the toxins    50 
4.5. Mass spectrometry of the toxins    50 
4.5.1. Selective ion complexes of ionophoric toxins in
 MS and MS/MS analysis   51 
 4.5.2. Mass spectrometric characteristics of the lipopeptide toxins
     and amylosin    53 
4.6. NMR analysis of amylosin    61 
4.7. Detection methods for cereulide and cereulide-producing strains 
 of B. cereus     62
4.8. Biological properties of the toxins   63 
4.8.1. Mammalian cells    63 
4.8.1.1. Cereulide    63 
4.8.1.2. Amylosin    64 
4.8.1.3. Surfactin and lichenysin A   64 
4.8.1.2. Cultured cells    65 
4.8.2. Bacillus toxins that altered functions of the mitochondria 65 
4.8.2.1. Cereulide    65 
4.8.2.2. Amylosin    66 
5
4.8.3. Ionophoretic properties of toxins analyzed with the
          black-lipid membrane (BLM) technique  68 
5. Conclusions and remarks    72 
5.1. Conclusions     72 
5.2. Remarks     73 
Tiivistelmä      77 
Acknowlegdements     79 
References      80 
6
List of original publications 
This thesis is based on the following publications:
I. Andersson, M.A., Mikkola, R., Helin, J., Andersson, M.C., and Salkinoja-
Salonen, M.S. 1998. A novel sensitive bioassay for detection of Bacillus 
cereus emetic toxin and related depsipeptide ionophores. Applied and 
Environmental Microbiology. 64:1338-1343. 
II Mikkola, R., Saris, N.-E., Grigoriev, P., Andersson, M.A., and Salkinoja-
Salonen M.S. 1999. Ionophoric properties and mitochondrial effects of 
cereulide- the emetic toxin of Bacillus cereus. European Journal of  
Biochemistry. 263:112-117. 
III. Mikkola, R., Kolari, M., Andersson, M. A., Helin, J., and Salkinoja-
Salonen, M.S. 2000. Toxic lactonic lipopeptide from food poisoning 
isolates of Bacillus licheniformis. European Journal of Biochemistry. 267: 
4068-4074.
IV. Mikkola R., Andersson M. A., Grigoriev P., Teplova V., Saris N-E.L., 
Rainey F.A., and Salkinoja-Salonen M.S. 2004. Bacillus amyloliquefaciens
strains isolated from moisture damaged buildings contained surfactin and a 
substance toxic to mammalian cells. Archives of Microbiology 181:314-
323.
V. Mikkola R., Andersson M.A., Teplova V., Grigoriev P., Kuehn T., Loss S., 
Tsitko I., Apetroaie C., Saris N.-E.L, Veijalainen P., and Salkinoja-Salonen 
M.S. 2006. Amylosin from Bacillus amyloliquefaciens, a K+ and Na+
channel forming toxic peptide containing a polyene structure. Submitted to 
Toxicon.
The publications are printed with kind permission of the American Society for 




AFC  atom/fragment contribution 
ATP  adenosine 5'-triphosphate 
BCF   bioconcentration factor 
BLM  black-lipid membrane 
CCCP  carbonyl cyanide m-chlorophenylhydrazone  
CFU  colony-forming unit 
CMC  critical micelle concentration 
COSY  correlation spectroscopy 
Da  dalton 
DDT  1,1,1-trichloro-2,2-di(4-chlorophenyl)ethane 
DMPC                                dimyristoylphosphatidylcholine 
DOPC  1,2-dioleoyl-sn-glycero-3-phosphocholine 
EEC  European Economic Community 
ERETIC  electronic reference to access in vivo concentrations  
ESI  electrospray ionization 
EU  European Union 
FCCP  carbonyl cyanide-p-trifluoromethoxyphenylhydrazone 
GC  gas chromatography 
GRAS  generally regarded as safe 
IT-MS  iontrap mass spectrometry 
HSQC  heteronuclear multiple quantum correlation 
m/z  mass-to-charge ratio  
MS  mass spectrometry 
MALDI-TOF  matrix-assisted laser desorption/ionization time-of- flight 
MS/MS  tandem mass spectrometry 
NAD, NAD+ and NADH  nicotinamide-adenine dinucleotide and its oxidized and 
reduced forms 
NK  natural killer 
NMR  nuclear magnetic resonance 
PCB  polychlorinated biphenyls 
PN  pyridine nucleotides 
PTP  permeability transition pore 
QSAR  quantitative structure-activity relationship 
TQ-MS  triple quadrupole mass spectrometry 
RLM  rat liver mitocondria 
ROS  reactive oxygen species 
RP-HPLC  reversed-phase high-performance liquid chromatography 
SMILES  simplified molecular input line entry system 
SPE  solid-phase extraction 
TOCSY  total correlation spectroscopy 
UV  ultraviolet 
8
Abstract
We report here the structures and properties of heat-stable, non-protein, and mammalian 
cell-toxic compounds produced by spore-forming bacilli isolated from indoor air of 
buildings and from food. Little information is available on the effects and occurrence of 
heat-stable non-protein toxins produced by bacilli in moisture-damaged buildings. Bacilli
emit spores that move in the air and can serve as the carriers of toxins, in a manner similar 
to that of the spores of toxic fungi found in contaminated indoor air. Bacillus spores in 
food cause problems because they tolerate the temperatures applied in food manufacture 
and the spores later initiate growth when food storage conditions are more favorable. 
Detection of the toxic compounds in Bacillus is based on using the change in mobility of 
boar spermatozoa as an indicator of toxic exposure. GC, LC, MS, and nuclear magnetic 
resonance NMR spectroscopy were used for purification, detection, quantitation, and 
analysis of the properties and structures of the compounds. Toxicity and the mechanisms 
of toxicity of the compounds were studied using boar spermatozoa, feline lung cells, 
human neural cells, and mitochondria isolated from rat liver. The ionophoric properties 
were studied using the BLM (black-lipid membrane) method. 
One novel toxin, forming ion channels permeant to K+ > Na+ > Ca2+, was found and named 
amylosin. It is produced by B. amyloliquefaciens isolated from indoor air of moisture-
damaged buildings. Amylosin was purified with a RP-HPLC and a monoisotopic mass of 
1197 Da was determined with ESI-IT-MS. Furthermore, acid hydrolysis of amylosin 
followed by analysis of the amino acids with the GS-MS showed that it was a peptide. The 
presence of a chromophoric polyene group was found using a NMR spectroscopy. The 
quantification method developed for amylosin based on RP-HPLC-UV, using the 
macrolactone polyene, amphotericin B (MW 924), as a reference compound. 
The B. licheniformis strains isolated from a food poisoning case produced a lipopeptide, 
lichenysin A, that ruptured mammalian cell membranes and was purified with a LC. 
Lichenysin A was identified by its protonated molecules and sodium- and potassium- 
cationized molecules with MALDI-TOF-MS. Its protonated forms were observed at m/z
1007, 1021 and 1035. The amino acids of lichenysin A were analyzed with ESI-TQ-
MS/MS and, after acid hydrolysis, the stereoisomeric forms of the amino acids with RP-
HPLC.
The indoor air isolates of the strain of B. amyloliquefaciens produced not only amylosin 
but also lipopeptides: the cell membrane-damaging surfactin and the fungicidal fengycin. 
They were identified with ESI-IT-MS observing their protonated molecules, the sodium- 
and potassium-cationized molecules and analysing the MS/MS spectra. The protonated 
molecules of surfactin and fengycin showed m/z values of 1009, 1023, and 1037 and 1450, 
1463, 1493, and 1506, respectively. 
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Cereulide (MW 1152) was purified with RP-HPLC from a food poisoning strain of B.
cereus. Cereulide was identified with ESI-TQ-MS according to the protonated molecule 
observed at m/z 1154 and the ammonium-, sodium- and potassium-cationized molecules 
observed at m/z 1171, 1176, and 1192, respectively. The fragment ions of the MS/MS 
spectrum obtained from the protonated molecule of cereulide at m/z 1154 were also 
interpreted. We developed a quantification method for cereulide, using RP-HPLC-UV and 
valinomycin (MW 1110, which structurally resembles cereulide) as the reference 
compound. Furthermore, we showed empirically, using the BLM method, that the emetic 




The many species of the genus Bacillus produce valuable metabolites with the potential 
for technical and scientific applications. On the other hand, several strains of Bacillus
species also produce compounds toxic to mammalian cells. It is worth noting that some 
Bacillus species with a GRAS (generally regarded as safe) status are able to produce 
toxins. Bacillus species are able to produce physically and chemically resistant endospores 
if the conditions needed for the vegetative bacteria to survive are limited. These spores can 
survive extreme environmental conditions such as dryness, heat, radiations and chemical 
treatments. For instance, it was shown that B. pumilus spores were resistant to the 
ultraviolet (UV) radiation conditions occurring on Mars (Newcombe et al. 2005). Such 
resistant endospores can remain dormant for long periods and are one reason why Bacillus
species are ubiquitous in diverse environments. The ubiquitous nature of Bacillus species 
(McKillip 2000) suggests that certain toxic strains of the Bacillus group are likely to be 
common in water-damaged indoor environments and in food. The toxins produced by 
Bacillus can be divided into the heat-labile, such as proteins, and heat-stable such as 
peptides. Information on the chemical and biological properties and evaluation of the 
toxicity, frequency and dose of exposure form the basis on which estimations of hazardous 
effects can be made.The heat stability and resistance of the toxins to enzymes indicate 
persistence in environment, whereas high levels of hydrophobicity suggest that the 
substances may permeate the cell membrane and accumulate in the fatty tissues. The 
present study is focused on those indoor air and food poisoning Bacillus species that 
produce environmentally resistant heat-stable non-protein compounds toxic to mammalian 
cells.
1.1. Microbes and toxic metabolites contaminating food
In most food poisoning cases the source of intoxication remains unknown (McCabe-
Sellers & Beattie 2004). On the other hand, when bacteria are responsible for poisonings, 
serious foodborne illnesses may occur. Bacillus species are capable of forming spores and 
growing under both aerobic and anaerobic conditions, indicating that it is almost 
impossible to avoid Bacillus contamination in food. Other foodborne hazards are caused 
by the spore-forming bacteria Clostridium perfringens and C. botulinum, which grow 
under anaerobic conditions. Most Bacillus strains are believed to be harmless if found in 
low concentration such as < 1000 colony forming units (CFU)/g. However, at suitable 
growing temperatures (20-50 °C) an organism such as B. cereus may multiply in 20 min 
(Maier et al. 1999). This means that starting from < 1000 CFU/g it requires less than 1.5 
hours to reach >10 000 CFU/g, which is considered as a food spoilage amount of B.
cereus (Notermans and Batt. 1998, Gilbert et al. 2000). Furthermore, certain Bacillus
strains are pathogenic and form hazardous toxic metabolites. Therefore, serious bacterial 
food poisonings are usually ill-fated combinations of improper food handling and 
accidents.
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It was estimated that in the USA food poisoning cases annually cost 2-3 billion dollars 
(McCabe-Sellers & Beattie 2004) and that every year there are 27 000 cases in which B.
cereus is involved (Mead et al. 1999). Bacillus cereus caused 104 documented food 
poisoning outbreaks in Taiwan and 50% of the ready-to-eat food items contained B. cereus
(Fang et al. 2003). As many as 5% of foodborne outbreaks have been connected with B.
cereus in the Netherlands, England, France, and the USA (Rosenquist et al. 2005). Food 
intoxications in Japan caused by B. cereus during 1982-2001 were especially of the emetic 
types (Kawamura-Sato et al. 2005). 
The strains of B. cereus produce food poisoning protein and peptide toxins: as many as 10 
different heat-labile protein enterotoxins causing abdominal cramps, diarrhea, and nausea 
and the heat-stable peptide toxin cereulide which causes vomiting (Kotiranta et al. 2000). 
Some of these enterotoxins are formed in the gut and cause problems when food 
containing live toxin-producing bacteria is ingested (Le Loir et al. 2003). Heating of food 
at high temperature may prevent this intoxication by killing the vegetative bacteria and 
destroying the heat-labile enterotoxins. The situation is a different with the heat-stable 
toxins, because they may pass through many food-processing steps before causing 
intoxication.
Foodborne bacteria such as Staphylococcus aureus, Escherichia coli, and C. perfringens
also produce several heat-stable protein enterotoxins that cause intoxication at low 
nanogram concentrations (Bennett 2005, Balaban and Rasooly 2000, Schmitt et al. 1999,
Le Loir et al. 2003, Lund et al. 2000, Shatursky et al. 2000). Escherichia coli, B. cereus, 
C. botulinum and C. perfringens produce heat-labile protein enterotoxins. The E. coli
enterohemorrhagic heat-labile protein toxin causes bloody diarrhea and C. botulinum heat- 
labile botulin causes botulism. The enterotoxins are either a single protein such as the B.
cereus enterotoxins cytotoxic CytK (34 kDa,  Lund et al. 2000), hemolysin I, 55 (kDa), 
hemolysin II (30 kDa), mouse lethal toxin (MLT, 33-34 kDa, Shinagawa et al. 1991) and 
enterotoxin FM (45 kDa, Asano et al. 1997) or multi component proteins as hemolytic 
three-unit hemolysin BL (HBL) which consists of 36-, 35-, and 45- kDa proteins (Beecher 
et al. 1995a) or nonhemolytic enterotoxin (NHE), a three-component toxin consisting of 
39-, 45-, and 105-kDa proteins (Lund and Granum 1996). Most of the enterotoxins act as 
porins in cells of the small intestinal epithelium causing diarrhea, abdominal cramps, and 
pain (Laohachai et al. 2003, Le Loir et al. 2003). Some are both hemolytic and cytotoxic 
(Schmitt et al. 1999, Lund et al. 2000). 
Cereulide is a heat-stable cyclic dodecadepsipeptide (Agata et al. 1994), tolerating 
autoclaving at 121 °C for 15 min (Shinagawa et al. 1995), pH 2 and 11, and proteolytic 
enzymes. Thus it appears impossible to inactivate it during normal food-processing 
procedures. In fatal food poisoning cases caused by B. cereus (Mahler et al. 1997, Dierick 
et al. 2005) the fulminant liver failures of patients were connected with cereulide 
intoxication. The concentrations provoking the acute toxicity effect of cereulide in humans 
and monkeys were estimated as 8-10 μg /kg of the body weight (Agata et al.1995, 
Shinagawa et al. 1995, Jääskeläinen et al. 2003a).
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The protein enterotoxins produced by C. perfringens can cause problems by 
contaminating various meat products, whereas C. botulinum and the protein toxin botulin 
are found in contaminated smoked fish, honey, and canned products. The B. cereus spores 
were hydrophobic and accumulated in the fat droplets of milk, e.g. when B. cereus was 
found in 56% of pasteurized milk samples (Larsen and Jorgensen 1997). When 325 food 
samples were examined, one third of the total and half of the cream cheese and spreading 
butter samples contained B. cereus (Schlegelova et al. 2003). Of 48 901 ready-to-eat food 
samples examined 98.7% contained B. cereus-like organisms at concentrations of < 1000 
CFU/g, 0.7% at 1000-10 000 CFU/g, and 0.5 % at >10 000 CFU/g. The samples of 
cucumber, tomato (2.6%), rice (1.3%), dessert with milk and flour (1.0%), dessert with 
milk and rice (3.1%), and cake custard (1.2%) contained >10 000 CFU/g of B. cereus
(Rosenquist et al. 2005). Studies of B. cereus growing in food products show that in meat, 
rice, and milk products the B. cereus doubling times vary from 20 min to 3 h at 30 °C. The 
lowest doubling times were in milk (20-36 min), cooked rice (26-31 min), and infant 
formulas (56 min) (Sutherland et al. 1996). Thus, in the milk and cooked rice B. cereus is 
able to multiply from 1000 CFU/g to 10 000 CFU/g in 1-2 h and infant formula in 3 h.
Recently, it was reported that cereulide-producing B. cereus were isolated from 
commercial infant foods (Shaheen et al. 2006). Spores of all cereulide-producing B. cereus
strains were more heat-resistant and the average amount of germinating spores were 
higher for cereulide-nonproducing B. cereus strain spores at a temperature range of 4-48 
°C (Carlin et al. 2006 ). In contrast, most psychrotrophic isolates of B. cereus are mainly 
unable to produce cereulide; the first was reported only recently (Altayar and Sutherland. 
2006). Food poisoning isolates of psychrotrophic B. cereus strains were connected with 
the production of enterotoxins (Dufrenne et al. 1995). 
Cereulide production in B. cereus strains is dependent on growing conditions: pH, 
temperature, oxygen, amino acids, growth media, or food. The growing conditions of 
those B. cereus strains capable of producing cereulide vary (Rajkovic, et al. 2006). The B.
cereus strains 5964a and NS117 produced more cereulide when growing in nonshaken vs. 
shaken milk, while the aeration of cultures negatively affected cereulide production 
(Rajkovic et al. 2006). The B. cereus strain F4810/72, growing in baby food, also grewn 
better under stationary conditions (Shaheen et al. 2006), while the B. cereus strains 
NC7401 and F4810/72 produced less cereulide in static incubations compared with 
incubation on a rotary shaker (the cultures were grown in trypticase soy broth) (Häggblom 
et al. 2002). The cereulide production in B. cereus strains B203, B116 and F-4810/72 was 
increased in the presence of oxygen (Jääskeläinen et al. 2004). Cereulide production was
reduced when B. cereus strain NC7401 grew in food at low pH (Agata et al. 2002). The 
amino acids L-Leu, L-Val, and L-Thr were essential to cereulide production in B. cereus 
strain NC7401 (Agata et al. 1999, Kuse et al. 2000). Addition of the amino acids L-Leu
and L-Val increased cereulide production in B. cereus strains B203, B116, and F-4810/72 
(Jääskeläinen et al. 2004).
Bacillus species, other than B. cereus, e.g. B. subtilis, B. licheniformis, and B. 
amyloliquefaciens were also associated with food poisoning cases (Kramer and Gilbert 
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1989, Beattie and Williams 1999, Salkinoja-Salonen et al. 1999a). Putative emetic toxins 
were produced by strains of B. subtilis, B. mojaviense, and B. pumilus isolated from tap 
water, foods, and spices (From et al. 2005). Infant cereals and dried formulas causing 
vomiting were associated with B. subtilis and B. cereus contamination (Duc et al. 2005). 
Several species of Bacillus are capable of producing heat-stable non-protein compounds 
toxic to eukaryotic cells, hence are potentially able to intoxicate food products. 
Various non-protein heat-stable mycotoxins are produced by molds such as Aspergillus,
Fusarium, and Penicillium growing in wet crop fields or when cereals, grain, corn and 
peanuts are stored under moist conditions. These mycotoxins include aflatoxins (Frisvad 
et al. 2005, McKean et al. 2006), fumonisins (McKean et al. 2006), zearalenone (Alm et 
al. 2006), ochratoxin (Ringot et al. 2006), T-2, diacetoxyscirpenol, deoxynivalenol 
(vomitoxin), and nivalenol from the trichothecene group (Schollenberger et al. 2006), all 
of which are acutely toxic and have caused human illness. Trichothecenes induced 
apoptosis and caused vomiting (Rocha et al. 2005). The toxicity of deoxynivalenol, 
zearalenone and fumonisin B1 targetted the mitochondria in a human intestinal cell line 
Caco-2 (Kouadio et al. 2005). Deoxynivalenol, T-2 toxin, and zearalenone were toxic to 
three human epithelial cell lines at exposure concentrations from 100 ng/ml to 1 μg/ml
after 2-4-d exposures (Calvert et al. 2005). Ochratoxin A inhibited mitochondrial 
respiration and disturbed cellular signaling and regulation (Ringot et al. 2006). 
Moniliformin from Fusarium is cardiotoxic and also affects smooth muscle cells (Kamyar 
et al. 2006). The cation-selective channel-forming mycotoxins beauvericin and enniatin 
are produced by Fusarium frequently found in corn, cereals, and grain (Logrieco et al. 
2002, Jestoi et al. 2004, Kamyar et al. 2004, Kouri et al. 2005). 
1.2. Microbes and toxic metabolites in moisture-damaged 
buildings
There is indication that over half of the buildings in Finland have moisture problems 
(Koskinen et al. 1999, Lappalainen et al. 2001). Mold problems have been reported in as 
many as 27-56% of buildings in North America, 15-48% in Europe and 15% in Finland  
(Górny et al. 2002). These data suggest that moisture damage and mold problems affect an 
enormous number of people in Finland. In 2004 there were 1.4 million buildings in 
Finland (Tilastokeskus (Statistics, Finland) 2005), suggesting that 700 000 moisture- 
damaged and 200 000 moldy buildings exist in Finland. This is due mainly to our climate 
and also the energy crisis during the 1970s, which affected building technology in 
Scandinavia (Bornehag et al. 2005). Building materials such as gypsum liners, insulation 
materials, and plastic flooring together with the moisture problem, offer suitable 
environments for microbes.
Molds, fungi, bacteria, and their metabolites cause health problems in water-damaged 
buildings (Husman 1996, Andersson et al. 1997, 2005, Peltola et al. 1999, 2001, 
Salkinoja-Salonen et al. 1999b, Suominen et al. 2001, Nevalainen and Seuri 2005). Fungi 
such as Fusarium, Aspergillus, Penicillium, and Stachybotrys have been associated with 
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asthma, allergy, and rhinitis in indoor air (Nevalainen et al. 1992, Andersson et al. 1997) 
(see also Chapter 1.1). Trichoderma harzianum isolated from moisture-damaged buildings 
produces peptaibols toxic to mammalian cells (Peltola et al. 2004).
Most indoor air studies have been focused on the problems caused by molds and fungi 
whereas the role of bacteria and their toxins has remained more or less unclear. The spores 
of Streptomyces californicus and B. cereus isolated from indoor air induced inflammatory 
responses in murine macrophages and reduced cell viability more efficiently than did the 
spores of Penicillium, Aspergillus and Stachybotrys (Hirvonen et al. 2005). Bacteria grow 
more rapidly than fungi and may be the first microbes to cause problems in moisture-
damaged buildings. Bacteria such as Streptomyces griseus, which produce valinomycin, 
were reported from moisture-damaged buildings (Andersson et al. 1998), as was B. cereus,
which produces cereulide, from construction materials (Mikkola et al. 1999) and from 
settled dust and building materials (Andersson et al. 2002). The occurrence of S. griseus
was connected with moisture damage in houses (Rintala et al. 2004). Inhalation of 
Bacillus spores can serve as routes for toxin exposure, as can inhalation of fungal spores 
and their toxins (Kuhn et al. 2005, Black et al. 2006). 
Persistent and hydrophobic non-protein toxins such as valinomycin or cereulide may sorb 
into hydrophobic indoor materials such as plastic products. Degradation of these 
substances by mammalian or microbial enzymes has not been reported. Therefore, such 
substances may remain active long after being produced. In contrast, protein toxins are 
sensitive to microbial enzymes and can be inactivated by environmental conditions such as 
heat, pH changes, or draft. However, protein toxins may also cause damage because the 
bacteria or their toxins can be transported as aerosols or dust into contact with the skin or 
respiratory tracts of occupants. Indeed, B. cereus secretes protein toxins such as pore-
forming HBL, NHE and phospholipases that are associated with the incidence of a serious 
eye disease, endophthalmitis (Beecher et al 1995b, 2000). One of the well-known 
hazardous bacteria, B. anthracis, is a close relative of B. cereus and produces the protein 
anthrax toxins. Examples of other protein toxins produced by Bacillus are the fungicidal 
entomocin 9 produced by B. thuringiensis (Cherif et al. 2003), as well as hemolytic 
cereolysin, and necrotic and hemolytic CytK produced by B. cereus (Shinagawa 1991, 
Lund et al. 2000). The ribonuclease called barnase is produced by B. amyloliquefaciens,
provokes failures in perfused rat kidney of (Ilinskaya and Vamvakas 1997), and is 
cytotoxic to human cells (Prior et al. 1996). 
High levels of Bacillus species in the indoor air generally indicate previous water damage 
and lack of adequate maintenance of the building or house. Infants, the elderly, and other 
individuals with immune system deficiencies are sensitive to microbial contaminations of 
indoor air. Occupants of moisture-damaged buildings suffer from irritations of the eyes, 
illnesses of the upper and lower respiratory systems, tiredness, faintness, allergies, and 
neurological problems (Peltola et al. 2001).
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1.3. Overview of the industrial applications of Bacillus species
Bacteria of the Bacillus group are widely used for the manufacture of important industrial 
enzymes, food products, pesticides, and insecticides (Fogarty and Kelly 1990, Beynon and 
Beaumont 1998, Outtrup and Jörgensen 2002). Bacilli secrete exocellular enzymes (Priest 
1977), e.g. α-amylases and proteases, producing over one-half of the total commercial 
enzyme volume (Crueger and Crueger 1982, Fogarty and Kelly 1990). The proportions of 
enzymes of Bacillus origin used in the technical, food, and feed industries constitute 56%, 
29%, and 15%, respectively of the total enzyme market in 1999 (Outtrup and Jorgensen 
2002). One example is serine proteinase subtilisin (stable under alkaline conditions), 
important to detergent industry, which is produced by B. licheniformis and B.
amyloliquefaciens. Alkaline proteases are used in many protein hydrolysates as infant food 
formulations (Gupta et al. 2002). Bacillus subtilis (natto) is used for the fermentation of 
soy.
Certain strains of Bacillus have GRAS status and are used in industry and agriculture 
(Schallmey et al. 2004). Bacillus thuringiensis, which closely related to B. cereus, emits 
effective CryT proteins against insect larvae that are used as an insecticidal (Schallmey et 
al. 2004). Due to their ability to form spores, Bacillus species can be easily stored for later 
applications, such as pesticide use. 
Bacillus amyloliquefaciens strain RC-2 containing iturins (Yoshida et al. 2001, Hiradate et 
al. 2002), has been proposed as an agent to protect mulberry leaves against Colletotrichum
dematium. Bacillus amyloliquefaciens strain FZB24 is a commercial biopesticide 
producing the auxin indole-3-acetic acid, and the enzyme phytase (Kilian et al. 2000, 
Idriss et al. 2002). Bacillus species are also used as feed additives; e.g B. subtilis, B.
licheniformis, and B. pumilus are used in fermentation processes in foods such as ugba, 
ogiri, ogiri-saro, and dawadawa in Africa and natto, thua-nao, and kinema in Asia 
(Beaumont 2002, Amoa-Awua et al. 2006). Certain Bacillus species produce nature’s 
most powerful biosurfactants such as surfactin from B. subtilis or lichenysin A from B.
licheniformis, which has been considered for use in improving oil recovery (Schaller et al. 
2004). Such biosurfactants have also been considered for medical use (Singh and 
Cameotra 2004). Many strains of Bacillus produce several bacteriocin-like substances, e.g. 
some strains of B. cereus produce the bacteriocin cerein 7, a pore-forming peptide of 3940 
Da (Oscariz et al. 1999, Oscariz and Pisabarro 2000). The lantiobiotics are lanthionine-
containing peptide antibiotics, such as mersacidin (1825 Da) from Bacillus strains HIL-
Y85, 54728, which is active against methicillin-resistant Staphylococcus aureus MRSA 
strains (Chatterjee et al. 2005). The bacteriocin subtilin, produced by B. subtilis ATCC 
6633, structurally resembles nisin and inhibits the germination of spores of Clostridium
and B. cereus (Chatterjee et al. 2005). 
The usefulness and application of many Bacillus species and, on the other hand, their 
ability to produce toxic compounds call for careful monitoring of their environmental 
occurrence. Recently, one commercial enzyme producer published data on the non-
toxicity of their enzyme-producing Bacillus strains (Pedersen et al. 2002). 
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1.4. Properties and biological effects of non-protein toxins from 
the genus Bacillus
Many microbial peptides are synthesized non-ribosomally by peptide synthetases which 
are multienzyme complexes (Hancock and Chapple 1999). Bacillus subtilis and B.
amyloliquefaciens use 4-7% of their genomes for producing bioactive compounds (Stein 
2005). Cereulide from B. cereus is also produced non-ribosomally (Horwood et al. 2004, 
Ehling-Schulz et al. 2005a) and recently it was shown that cereulide production is 
plasmid-mediated (Hoton et al. 2005). Bacillus subtilis strain A1/3 is exceptionally rich in 
the genes coding for synthetases of polyketides and non-ribosomal peptides and produces 
nine different bioactive compounds (Hofemeister et al. 2004). 
Surfactin, lichenysin A, fengycin, tyrocidine, bacitracin and mycosubtilin are produced by 
non-ribosomal peptide synthesis (Konz et al. 1997, Mootz and Marahiel 1997, Yakimov et 
al. 1998, Duitman et al. 1999, Koumoutsi et al. 2004). Approximately 300 precursors for 
non-protein compounds have been found, whereas peptide production is limited to a range 
of 2-48 residues, in contrast to ribosomal synthesis in which 21 different amino acids are 
used for peptide or protein production (Marahiel et al. 1997). The Bacillus group produces 
a diverse collection of antibacterial, antiviral or antitumoral compounds, and some are 
toxic to eukaryotic cells. The toxins belong to various chemical groups, as listed in Table 
1 and Figure 1. The structures include cyclic lipopeptides and cyclic peptides, 
phospholipid oligopeptides, a small-molecular-weight compound with functional amine 
groups NH2 as the side chain, and cationic sugar derivatives. The peptides have molecular 
masses in the range from 500 to 4000 Da and those of non-peptides from 129 to 555 Da, 
averaging 1000 Da and 300 Da, respectively.
Most of the toxic non-protein substances from Bacillus, such as those listed in Table 1, are 
well known but their role as contaminants in food or moisture-damaged buildings is 
incompletely understood. The reasons are historical, since most of these substances were 
found mainly before 1980, whereas the toxicity or poisoning related to such substances 
was established much later. For instance, the microbial role in indoor air problems has 
been studied for the past 20 years and only in the recent years has the role played by 
bacterial metabolites received justified attention. Most of the studies have been focused on 
those Bacillus species with capable of producing antimicrobially active substances for 
medical purposes or for protecting agricultural crops. However, many Bacillus-derived
antibiotics, e.g. tyrocidine, gramicidin S, and polymyxin B, are too toxic for use as drugs 
administered orally. Several compounds produced by Bacillus and related genera are 
fungicidal. The fungal cell resembles the mammalian cell in having similar organelles and 
phospholipid membranes, except that fungi contain ergosterol instead of cholesterol. It is a 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































XIX. Rhizoticin XX. Macrolactin A
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XXI. Gramicidin A
Figure 1. Structures of compounds toxic toward eukaryotic cells produced by strains of Bacillus 
and species of related genera. R in the structures stands for n- , iso,- and anteiso- branching 
hydrocarbons with different lengths (C10-C20), depending on the compounds. In compound XIX, R 
= H or Val.
Bacillus strains produce compounds (Table 1 and Fig. 1) that alter the functions of 
biological membranes in different ways. Substances affecting the plasma membrane 
integrity (such as I, II in Fig. 1) may cause leaking of the cell contents, initiating necrosis. 
Ionophoric substances (such as V, XII, XXI in Fig. 1) form ion channels or operate as ion 
carriers. Such substances alter the permeability of plasma and/or organelle membranes.
Maintenance of the transmembrane electrical potential as well as the proper ionic 
concentrations of cells or organelles is critical to cellular functions. Many biochemical 
functions are regulated by ion fluxes across membranes: signals, transporting properties, 
adenosine 5'-triphosphate (ATP) production, maintenance of the cell size, and change in 
the conformation of integral membrane proteins, disturbing immunological recognition. 
Membrane potential differences alter the conformation of membrane proteins such as 
Na+/K+ channels and may initiate apoptosis (Bacso et al. 1996). 
Thus, there are good reasons for investigating indoor air and food environmental Bacillus
strains for their abilty to produce toxic compounds. The experimental work and the 
literature review in this thesis evaluate the potential hazards of non-protein heat-stable 
compounds produced by strains of Bacillus and related genera. 
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1.4.1. Lipopeptides 
Several species of the genus Bacillus produce various lipopeptides (Table 1 and Fig. 1). 
Bacillus lipopeptides consist of a peptide part containing 7-11 amino acids, either cyclic or 
linear or a combination of these. β-hydroxy or β-amino fatty acids form the lipid part 
connected to the peptide backbone. Lipopeptides are thus amphiphilic, in which acid or 
basic amino acids serve as polar groups and fatty acids partly as neutral hydrophobic 
moieties, most are active biosurfactants. The hydrocarbon length of the fatty acids and 
amino acid composition may vary, depending on the nutrition of the bacteria, and affect 
the properties of the lipopeptides. The cyclic structure of the peptide part protects the 
lipopeptide from enzymatic cleavage and maintains its general stability. Many 
lipopeptides show antimicrobial or antiviral activity and affect mammalian cell functions. 
Both the phospholipids of the biomembranes and the lipopeptides have amphilic 
structures. Thus, lipopeptides are capable of penetrating into cells, with the lipophilic 
hydrocarbon chain interacting with the plasma membrane lipid moiety while the polar 
amino acids in the peptide part interact with the polar phosphatidyl moieties. Whether 
lipopeptides are able to damage the integrity of the plasma membrane or create ion- 
selective pores depends on the nature of the lipopeptides and on the phospholipids of the 
membranes.
1.4.1.1. Lipopeptides of the surfactin family 
Lipopeptides of the surfactin family (surfactin, lichenysins, and pumilacidins) contain a 
cyclic heptapeptide acylated with β-hydroxy fatty acids. The length of the carbon chain of 
β-hydroxy fatty acids ranges from C13 to C18 with n, iso, or anteiso branchings. These 
peptides are powerful biosurfactants, produced by strains of several Bacillus species. 
Since surfactin (I in Fig. 1 and Fig. 2) was discovered (Arima et al. 1968) and synthesized 
(Nagai et al. 1996), its properties have been studied widely and interesting applications 
from industry to medical use were proposed (Singh and Cameotra 2004). Surfactin (I in 
Fig. 1 and Fig. 2) contains a heptapeptide (Glu1-Leu2-Leu3-Val4-Asp5-Leu6-Leu7). The 
natural analogue as lichenysin A (II in Fig. 1 and Fig. 2) has Gln in position 1 and Ileu at 
position 7 and pumilacidin has Leu at position 4, whereas other variations are located at 
position 7. Lichenysin A is produced by B. licheniformis during anaerobic and aerobic 
growth. It was first isolated from oil wells and its structure was elucidated by Yakimov et 
al. (1995, 1999).
Surfactin in concentrations of 30-64 μM was cytotoxic to several human and animal cell 
lines (Vollenbroich et al. 1997) and provoked hemolysis (Dufour et al. 2005). Lichenysin 
A had a stronger surfactant effect and was hemolytic at 10-times lower concentration (15 
μM) than surfactin (Grangemard et al. 2001). Surfactin was reported to lyse protozoan 
membranes (Gould et al. 1971) and to inhibit starfish oocyte maturation at a concentration 
of 3 μM (Toraya et al. 1995). Surfactin showed insecticidal activity against the fruit fly 
Drosophila melanogaster (Assie et al. 2002). Inactivation of enveloped viruses such as 
vesicular stomatitis virus (VSV), simian foamy virus (SFV), and suid herpesvirus 1 (SHV-
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1) by surfactin depended on its hydrophobicity: the C14 and C15 isoforms were more 
antiviral than C13 (Kracht et al. 1999). The biological effects of surfactin and lichenysin A 
are probably due to their strong surfactant properties. However, surfactin also forms 
cation-selective K+ > Na+ channels in BLM (Sheppard et al. 1991). 
Surfactin-producing B. subtilis strains have high swarming motility and biofilm formation, 
whereas surfactin-nonproducing strains did not swarm or form biofilm (Connelly et al. 
2004). Surfactin promotes bacterial cell motion by lowering the surface tension (Kinsinger 
et al. 2003, Hofemeister et al. 2004, Mukherjee and Das 2005).
Surfactin
Lichenysin A 
Figure 2. Structures of surfactin and lichenysin A. Atom colors: blue is nitrogen, red is oxygen, 
gray is carbon, and white is hydrogen. 
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The amphiphilic structures of the lipopeptides surfactin (I in Fig. 1) and lichenysin A (II in 
Fig. 1) explain their ability to form micelles and to penetrate the plasma membrane. Their 
basic structures are closely similar (Fig. 2), containing a cyclic peptide with seven amino 
acid residues associated with the β-hydroxy fatty acid. The main difference is shown in 
Fig. 2 near a hydrocarbon of β-hydroxy fatty acids, since surfactin has Glu (oxygen [red] 
with an OH group) in contrast to lichenysin A Gln (nitrogen [blue] with an NH group). 
1.4.1.2. Lipopeptides of the iturin family 
Lipopeptides of the iturin family, such as iturins, bacillomycins (Table 1), and 
mycosubtilin (III in Fig. 1) contain a cyclic heptapeptide acylated with β-amino fatty acids 
with a chain length of C14 to C16 (Peypoux et al. 1978, Hourdou et al. 1989). Iturin A 
contains the heptapeptide Asn1-Tyr2-Asn3-Gln4-Pro5-Asn6-Ser7, whereas in the other 
members the amino acid residues in the heptapeptides vary slightly; e.g. mycosubtilin (III 
in Fig. 1) has Asn1-Tyr2-Asn3-Gln4-Pro5-Ser6-Asn7. 
Iturin A retained 100% biological activity after heating for 30 min at 100 °C and for 60% 
after autoclaving for 20 min at 120 °C, as measured with the fungal inhibition test (Yu et 
al. 2002). Another antifungal substance from B. subtilis YM was highly similar to iturin 
A, and heat-resistant at 100 °C for 1 h, and also resistant towards proteolytic enzymes 
(Chitarra et al. 2003).
Biological membranes consist of various lipids, sterols, and proteins all of which can 
affect the activity of channel-forming substances. Biological effects of the iturin family 
peptides are due to their capability of forming ion-conducting pores (Maget-Dana and 
Peypoux 1994). Iturin A and bacillomycin L (Table 1) provoked hemolysis and released 
potassium from erythrocytes (Latoud et al. 1986, Aranda et al. 2005). Iturin A induced 
morphological changes in human erythrocytes (Thimon et al. 1994). Iturin A, 
bacillomycins, and mycosubtilin (III in Fig. 1) formed channels in BLM (Maget-Dana et 
al. 1985a,b, Maget-Dana and Ptak 1990). Mycosubtilin altered the permeability of the 
plasma membrane, releasing nucleotides, proteins, and lipids from yeast cells (Besson and 
Michel 1989) and lysing erythrocytes (Besson et al. 1989).
The lipopeptides of the iturin family are more active in membranes containing cholesterol, 
such as mammalian cells, than in the ergosterol-containing fungal cells. Iturin A released 
K+ ions more actively from the cells of Saccharomyces cerevisiae mutants containing
cholesterol in the membrane instead of ergosterol (Latoud et al.1990). Nucleotides,
proteins, polysaccharides, and lipids leaked from S. cerevisiae cells exposed to iturin A 
(Latoud et al. 1987) while the lethal concentration in S. cerevisiae was 10-60 µg/ml 
(Besson et al. 1984). Iturin and bacillomycin L form ion pores by aggregation in the 
membranes and interacting with sterols (Quentin et al. 1982, Maget-Dana and Peypox 
1994, Volpon et al. 1999). Mycosubtilin formed pores in dimyristoylphosphatidylcholine 
(DMPC) membranes by interacting with the phospholipids, forming a (1:2) complex with 
cholesterol, thus stabilizing the ion pore (Maget-Dana and Ptak 1990).
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The Tyr residue in the peptide backbone of the iturin family peptides plays a role in 
interacting with sterols and forming pores. Bacillomycin L forms pores in membranes by 
interacting with sterols due to its Tyr residue which forms a hydrogen bond with the 
hydroxyl group of sterols (Volpon et al. 1999). The Tyr residue enhanced the membrane 
activity of iturin A (Harnois et al. 1989). The cyclic tridecapeptide mycobacillin (X in Fig. 
1) lacks the hydrocarbon tail and was proposed to bind cholesterol by its Tyr residue 
(Mukherjee and Bose 1978). 
Bacillus strains that produce iturins are applicable as fungicides. Iturin A was antagonistic 
against Fusarium oxysporum, which cause potato diseases (Han et al. 2005). Bacillus
amyloliquefaciens strain B94 produces iturins that inhibit fungal plant pathogens (Yu et al. 
2002). Bacillus subtilis strain FZB24 is used in commercial biocontrol products against 
fungal plant pathogens; it produces iturin resembling compounds (Kilian et al. 2000). 
Surfactin- and iturin-containing Bacillus strains have been used to promote plant growth.
The lipopeptides iturin A (Table 1) and surfactin (Fig. 2) together play a role in adhesion 
of B. subtilis on solid surfaces by changing the hydrophobicity of the cells (Ahimou et al. 
2000), similar to that by surfactin (1.4.1.1). The utilization of substrate is promoted in 
Bacillus by secreting of surface active substances like iturin or surfactin (Mukherjee and 
Das 2005).
Figure 3. Structure of fengycin. Atom colors are as in Fig. 2. 
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1.4.1.3. Fengycins and various lipopeptides
Fengycins (III in Fig. 1 and Fig. 3) and the structurally similar plipastatins (Table 1) are 
distinguished from the other lipopeptides by the way in which the β-hydroxy fatty acid is 
linked with the polar dipeptide which is associated with the cyclic octapeptide (Fig. 3). 
The cyclic structure of fengycin cyclo(D-allo-Thr1-L-Glu2-D-Ala3/D-Val3-L-Pro4-L-
Gln5-L-Tyr6-L-Ile7-D-Tyr8)D-Orn9-L-Glu10-β-OH-FA is formed when D-Tyr8 is 
connected with amide bonds to D-allo-Thr1 and D-Orn9 and forms a lactone bond with L-
Ile7 (XII in Fig. 1 and Fig. 3). The structure of fengycin A contains D-Ala3 instead of the 
D-Val3 of fengycin B. Fengycins have stereoisomeric composition different from those of 
plipastatin. Fengycins contain D-Tyr8 instead of the L-Tyr8 of plipastatins and L-Tyr6
instead of the D-Tyr of plipastatins (Volpon et al. 2000).
Hathout et al. (2000) reported from B. thuringiensis kurstaki HD-1 an antifungal 
compound structurally resembling plipastatin and fengycins. Fengycins and plipastatins 
inhibit phospholipase A2, an enzyme affecting inflammation, acute hypertensions, and 
blood platelet aggregation (Volpon et al. 2000). Bacillus thuringiensis strain CMB26 
produced an analogue of fengycin with a double bond in the fatty acid. It was fungicidal, 
bactericidal, and insecticidal, and more effective against fungi than was iturin or surfactin 
(Kim et al. 2004). In low molar ratios from 0.1 to 0.5 of fengycin/dipalmitoyl-
phosphatidylcholine (DPPC) membrane fengycin forms pores and at a ratio of > 0.66 it 
acts as a detergent that solubilities membrane (Deleu et al. 2005). Analogues of iturin and 
fengycin were reported with a double bond in the fatty acid part. The fatty acids in iturins 
were predominantly C16 and C17 (Vater et al. 2002, Deleu et al. 2005). Recently B. subtilis
strain GA1 was described as producing three lipopeptides: surfactin, fengycin, and iturins. 
It was effective against gray mold which causes disease in apples (Toure et al. 2004). 
Another group of cyclic hexapeptide lipopeptides contains six amino acids acylated with 
15-guanidino-n-hydroxypentadecanoic acid (bacillopeptins, fusaridins (Table 1) and LI-F 
(VIII in Fig. 1)). The fusaricidins (Kajimura and Kaneda 1997, Beatty and Jensen 2002) 
and LI-F (Kurusu et al. 1987, Kuroda et al. 2000) from Paenibacillus polymyxa were 
fungicidal and antibacterial. LI-F compounds containing an azole group were toxic to ddY 
mice (Kuroda et al. 2001). The target of the azole group containing fungicidals target is 
cytochrome P450 which is also present in mammalian cells (Yoshida 1988), while azole 
antibiotic drugs are toxic when administered orally (Mclean et al. 2002) and impair 
mitochondrial functions (Rodriquez and Acosta 1996). 
Interestingly, the first cyclic lipopeptide daptomycin (1620 Da) from Streptomyces
roseosporus has been approved (USA) for use as an antibacterial drug against gram-
positive bacterial infections as MRSA. It acts by forming ion channels in membranes and 
high doses may cause renal dysfunction (Silverman et al. 2003). 
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1.4.2. Miscellaneous Bacillus toxins
Rhizocticins (XIX in Fig. 1) produced by B. subtilis are oligopeptides with a phosphono 
group. Rhizocticins mislead the fungal peptide transport system with an oligopeptide part 
into transporting it inside the cell where the toxic phosphono group is realized (Kugler et 
al. 1990). The cyclic tridecapeptide mycobacillin (X in Fig. 1) is also produced by B.
subtilis. Mycobacillin liberates ATP from Aspergillus niger, causing depletion of energy 
(Chowdhury et al. 1998), and is hemolytic at an exposure concentration of 25 μg/ml
(Banerjee 1977). Bacillus cereus secretes the fungicidal octapeptide mycocerein of whose 
amino acid composition is similar to that of the iturin group (Wakayama et al. 1984).
Bacillus licheniformis F2.2 isolated from a fermented food produced plipastatin, surfactin, 
and the new 1193-Da non-peptide surfactant BL1193 (Thaniyavarn et al. 2003). 
The cationic surfactant polymyxin B (VII in Fig. 1) is a cyclic decapeptide from 
Paenibacillus polymyxa that is effective against gram-negative bacteria. It contains 2, 4 di-
aminobutyric acid (Rosenberg and Ron 1999). At least 15 different polymyxins have been 
found, e.g. mattacin 1157 Da (polymyxin M) produced by Paenibacillus kobensis M. It is 
structurally related to polymyxin B. Both bind to lipopolysaccharide (LPS), which is 
thought to be reason for their effectivity against gram-negative bacteria (Martin et al. 
2003). Polymyxin B caused renal dysfunction in 14% of patients treated with it against a 
multiresistant bacterial infection (Ouderkirk et al. 2003). The fungicidal 770-Da peptide 
A12-C was isolated from B. licheniformis 12 which contained Glu, Arg, Ala, Pro, Tyr and 
Orn (Galvez et al. 1993a). The strain B. licheniformis M-4 produces a 3400-Da fungicidal 
peptide fungicin M4 containing Glu, Arg, Pro, Tyr, Val, Met and Orn (Lebbadi et al. 
1994a).
Bacillus licheniformis strains also produce peptides called amoebicins (Table 1) because 
they inhibit the amoeba Naegleria fowleri. Bacillus licheniformis A12 produced two 
amoebicins, the peptides A12-A and A12-B, which had the same mass of 1430 Da and 
contained Asp, Glu, Ser, Pro, and Tyr (Galvez et al. 1993b). They were active against 
yeast, fungi, and bacteria, and ruptured membrane of the amoeba Naegleria fowleri.
Bacillus licheniformis D-13 produced three amoebicin peptides with the same masses 
(1870 Da) and contained Asp, Glu, Val, and Leu (Galvez et al. 1994). These amoebicins 
inhibited several bacteria and were cytotoxic to murine cells (Galvez et al. 1994). A12 and 
D13 tolerated heating at 100 °C for 30 min, pH 2.5, and activity of proteolytic enzymes. 
Peptide A12 lost 75% of its activity at pH 9.5 but D13 was active (Galvez et al. 1993b, 
1994). The B. licheniformis strain M-4 produced three antifungal amoebicins: 3000 - 
3200-Da peptides containing Asp, Glu, Ser, Thr, Pro, and Tyr (Lebbadi et al. 1994b). It 
was shown that amoebicin m4-A decreased the membrane potential of B. megaterium in a 
manner similar to that of gramicidin D, formed pores in liposomes, and finally lysed both 
of these (Lebbadi et al. 1994c). Bacitracin (XI in Fig. 1) produced by strains of B.
licheniformis and B. subtilis is known as an antibacterial substance but is also nephrotoxic 
(Butaye et al. 2003) and possesses fungicidal activity against Botrytis  cinerea (Gebhardt 
et al. 2002). 
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The peptide gramicidins and tyrocidine are produced by Brevibacillus brevis. Gramicidin 
S (V in Fig. 1) and tyrocidine are cyclic decapeptides. Tyrocidine is a group of compounds 
tyrocidine A (VI in Fig. 1), B, and C. Tyrocidine and gramicidin S cause hemolysis 
(Prenner et al. 1999, Qin et al. 2003). Both substances are toxic during internal use or 
when inhaled but are topically used to treat bacterial infections of the skin. Gramicidin S 
and the polymyxins share two unique features with antimicrobial peptides from animals, 
plants and insects: they are polycationic and amphipathic (Zhang et al. 2000). Linear 
gramicidin (gramicidin D, Dubos and Hotchkiss 1941) pentadecapeptide is a group of 
compounds A (90% of the total mixture), B, C, and D. The structure of gramicidin A (XXI 
in Fig. 1) is HCO-L-Val-Gly-L-Ala-D-Leu-L-Ala-D-Val-L-Val-D-Val-L-Trp-D-Leu-L-
Trp-D-Leu-L-Trp-D-Leu-L-Trp-NHCH2CH2OH. The amino acid residues of gramicidin A 
have hydrophobic side chains, D and L forms of amino acid residues alternate and both 
ends of the peptide are modified (blocked). Gramicidin A contains valine at the position 1 
and form head-to-head dimers (the β-helix coils) that act as H+-, K+-, Na+-selective
channels (Busath 1993). The K+ and Na+ channels of gramicidin A have selectivity ratio 
K:Na of 1:3 (Wallace 2000).
Bacillus sp. sunhua produces the 402-Da macrolactin A (XX in Fig. 1) which is a 
cytotoxic macrolide. A total of 45% of the macrolactin was stable after heating at 100 °C
for 30 min and 60-100% at pH 5-13, but it was unstable at less than pH 3 (Han et al. 
2005). Macrolactin A which inhibited B. subtilis (5 μg per agar plate) and Staphylococcus
aureus (20 μg per agar plate), was antiviral and cytotoxic to cancer cells in concentrations 
from 3 to 8 μg/ml (Gustafsson et al. 1989). Plans have been formed to use Bacillus sp. 
sunhua as a biocontrol agent in potato planting (Han et al. 2005).
Butirosin (XVIII in Fig. 1) is an aminoglycoside toxic to the kidney and is produced by B. 
circulans (Cox and Serpersu 1997). Bacilysocin is a 470-Da non-peptide produced by B.
subtilis 168. It is a new fungicide with a phosholipid structure (Tamehiro et al. 2002). A 
non-protein acetone-soluble substance from Bacillus atrophaeus inhibited growth of 
several fungi. It also affected plasma membranes and membrane organelles of the 
Ascosphaera apis pathogen of honeybee larvae (Youssef and Knobletta 1998). 
Bacillus pumilus is known to produde the antibiotic pumilacidins (Table 1). In addition 
some B. pumilus strains also produce compounds toxic to mammalian cells. The strains of 
B. pumilus originating from different environmental sources produced heat-stable and 
proteolysis-resistant toxins (Suominen et al. 2001). Strains of B. pumilus and B. simplex
producing compounds toxic to boar sperm were isolated from indoor air (Peltola et al. 
2001). Toxic strains of B. pumilus were also reported from the air of cotton mills (Hoult 
and Tuxford 1991). Munimbazi and Bullerman (1998) isolated from dried Ndagala fish a 
strain of B. pumilus that produced a heat-stable (121 °C, 15 min), pH (2-10)-stable and 
proteolytic enzyme-resistant antifungal peptide that was soluble in polar organic solvents. 
Recently, an antifungal and antibacterial substance of < 3 kDa and with an unknown 
structure was reported from B. pumilus; the substance was resistant to pronase and had a 
stable shelf life for of at least 8 d in agar (Bottone and Peluso 2003). 
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1.4.3. Cyclic depsipeptides 
In cyclic depsipeptides the peptide backbones consist of hydroxy acids together with 
amino acids, forming a cyclic structure. Cyclic depsipeptides are able to bind alkali metal 
ions to the cavity of the molecule, which makes them act as ionophores (Ballard et al. 
2002). A similar ion cavity is found in cyclic ethers such as 18-crown-6, which also binds 
potassium with six single-ion pairs of electrons of the oxygen atoms in the ether bonds. 
The ion-binding properties of the ionophoretic cyclic depsipeptides are depentent on the 
size of the ring and the complex-forming groups determining the cavity in which the ions 
fit. The conformations of cyclic depsipeptides are depentent on chemical environment, e.g. 
solvents or membrane lipids, which makes it possible to bind ions and to release the ions. 
Cereulide cyclo(D-Ala-D-O-Leu-L-Val-L-O-Val)3 (Fig. 4 and XIII in Fig. 1), whose 
structure was determined by Agata et al. 1994 and homocereulide cyclo(D-O-Leu D-Ala
L-O-Val-L-Val)2D-O-Leu-D-Ala-L-allo-O-Ileu-L-Val (Wang et al.1995) are potent
ionophores from B. cereus that structurally resemble valinomycin cyclo(D-Val-L-O-Ala-
L-Val-D-O-Val)3 (Fig. 4) from Streptomyces strains. These substances are cyclic 
dodecadepsipeptides and transport potassium ions across lipid membranes. Their 
structures take shape where single pairs of electrons of the oxygen atoms from the six 
ester bonds form complexes with potassium ion. Cereulide and valinomycin are carriers 
(not channel formers) for potassium and have the stereoisomer cyclo(DDLL)n
configuration. Interestingly, the some compounds that have the stereoisomeric 
cyclo(DLDL)n configuration are able to orientate in membranes so that they form tubular 




Figure 4. Stereo views of cereulide and valinomycin with the same atom colors in Fig. 2, in which 
violet is potassium ion. 
The stereo view in Fig. 4 shows how the outer layer forms a hydrophobic belt around the 
structurally similar valinomycin and cereulide, making them permeable through to the cell 
membrane. The inward-oriented oxygen atoms from six ester bonds can form with 
unpaired electron complexes with positively charged alkali metals and ammonium ions. 
The structures of cereulide and valinomycin make them hosts to ions of alkali metals such 
as Li+, Na+, K+, and Rb+. The size of the molecules cavity of is favorable for binding with 
potassium and also with the same-sized ammonium ion.
Cereulide (Fig. 4) is the only potassium ionophore carrier found in Bacillus species and it 
was synthesized by Isobe et al. (1995). Cereulide causes emetic symptoms (Agata et al. 
1995) and may cause fatal liver failure (Mahler et al. 1997). It was shown in many studies 
to be highly toxic to human cells such as colon, neural, airway epithelial, and HeLa cells 
(Jääskeläinen et al. 2003a), neural cells (Teplova et al. 2004), and triggers apoptosis in 
natural killer (NK) cells (Paananen et al. 2002). Cereulide was also found in construction 
materials (Mikkola et al. 1999) and indoor environments (Andersson et al. 2002). 
However, the mode of action and specific mitochondrial toxicity were not clear before 
1999, after which its ionophoretic properties were studied experimentally using BLM in 
this thesis. Valinomycin (Fig. 4) is regarded as extremely toxic (Sigma-Aldrich, material 
safety data sheets). Several valinomycin-producing Streptomyces griseus strains was 
found in air of elementary schools and settled dust of children day-care centers 
(Andersson et al. 1998). Streptomyces griseus strains were are commonly found in 
moisture-damaged buildings (Rintala et al. 2004). It was reported that B.
amyloliquefaciens (three strains out of the 18 studied), B. subtilis (one strain out of the 19 
studied) and B. pumilus (12 strains out of the 14 studied) also produced valinomycin 
(Wulff et al. 2002). Since Wulff et al. identified valinomycin using retention data of 
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HPLC without MS data, their results are uncertain. Cereulide could be considered as an 
analogue of valinomycin. Subtle changes in the outer layer hydrocarbons of the analogues 
can affect the stability constant of the valinomycin K+ complex, as shown in the work of 
Ovchinnikov (1974) and Teplova et al. (2006). Thus, valinomycin analogues such as 
cereulide will have different ionophoretic, properties depending on the K+ concentration in 
the environment. In vivo cereulide induced emetic symptoms in the Asian house shrew 
(Suncus murinus) at 13 μg/kg effective dose50 (ED50 value, oral administration) at doses 60 
times lower than valinomycin (Agata et al. 1995). The small structural difference between 
cereulide versus valinomycin changes the biological properties. The physical and chemical 
properties of cereulide and valinomycin are very similar, whereas the biological effects are 
different: cereulide is an emetic substance at low doses and the physiogical K+
concentration in (blood) cereulide is more active (Teplova et al. 2006). 
Bacillus cereus strains also produce homocereulide (Table 1) which resembles cereulide 
(see p. 27). Cereulide and homocereulide were cytotoxic toward murine leukemia and 
colon cancer cells at 18 pM (0.021 ng/ml) and 16 pM (0.018 ng/ml), respectively (Wang et 
al. 1995). Valinomycin possesses toxic activity toward VSV and some gram-positive, but 
not gram-negative bacteria (Pettit et al. 1999). Valinomycin provoked toxic effects similar 
to those of cereulide, inhibiting boar sperm cell motility and swelling mitochondria 
(Andersson et al. 1998) and causing apoptosis in NK cells (Paananen et al. 2000). 
Valinomycin caused apoptosis and intracellular acidification in murine hematopoietic cells 
(Furlong et al. 1998). Valinomycin was 500-10 000 times more cytotoxic than 
montanastatin, an analogue of valinomycin with a cyclic structure cyclo(D-Val-L-O-Ala-
L-Val-D-O-Val)2. Both compounds were coproduced by Streptomyces anulatus (Pettit et 
al. 1999). Valinomycin inhibited several gram-positive bacteria towards which 
montanastatin was inactive (Pettit et al. 1999). The ionophoric properties of montanastatin 
are unknown. 
1.5. Ionophores impair mitochondrial functions 
Mitochondria regulate cells in life and death, finally transmitting the apoptosis 
(programmed death) signal to the cell. In recent years impaired mitochondria were 
suspected of playing a role in the etiology of several chronic diseases (DiMauro and 
Davidzon 2005). 
1.5.1. Mitochondrial inner membrane functions 
Mitochondria are the site of ATP production associated with respiration of cells. The 
electron transfer chain (inner membrane, cristae Fig. 5 and Fig. 6), where complex II led 
by the citric acid cycle is located in the mitochondrial matrix. Sugars and fatty acids are 
used as fuels to build up an electric transmembrane potential (100-150 mV) in the 
mitochondria (Fig. 6). This potential energy is converted to chemical energy in the form of 
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ATP (V in Fig. 6,). As many as 90% of the reactive oxygen species (ROS) are generated 
by aerobic metabolism at steps I - IV of the respiratory chains in the mitochondrial inner 
membrane (Fig. 6). 
Figure 5. The mitochondria possess two membranes (orange) separated by intermembrane space 
(white), the permeable outer membrane around the mitochondria and the impermeable inner 
membrane which forms folds called cristae, as well as  the matrix (gray). 
Figure 6. Functions of the mitochondrial inner membrane: I, NADH dehydrogenase (proton 
pump); II, The succinate dehydrogenase (S) which is part of the tricarboxylic acid cycle, coenzyme 
Q (Q); III,  cytochrome c reductase (proton pump), cytochrome c (C); IV, cytochrome c oxidase 
(proton pump, conversion of  oxygen to water); V, ATP synthase. 
1.5.2. Ionophores have different effect on mitochondria, impairing their 
functions
An intact inner membrane is essential for maintaining electrical potential in the 
mitochondria. Ionophores decrease inner membrane potential and increase oxidative stress 
by forcing mitochondria to maintain membrane potential, causing higher oxygen 
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consumption and increase in ROS. High contents of ROS can damage the unshielded 
mitochondrial DNA. Mutations in circular mitochondrial DNA were associated with 
several diseases (DiMauro and Davidzon 2005). Ionophoretic toxins destroy the osmotic 
balance of cell and interfere with ATP production. 
A decreased mitochondrial inner membrane potential triggers apoptotic cell death. Toxins 
can damage mitochondria so that they become inefficient, similar to the situation noted in 
studies on aging. It was observed that old mice had more lymphocytes with lower 
mitochondrial membrane potentials than young mice (Mather and Rottenberg 2002). It was 
also shown that aged neurons have significantly reduced mitochondrial membrane 
potential (Murchison el al. 2004). Continued exposure to potassium ionophores may induce 
osmotic swelling and lysis of mitochondria. 
There are other ionophores known as food contaminants that may cause problems similar 
to those caused by cereulide. Enniatins A, B are cyclohexadepsipeptide from the fungus 
Fusarium and form K+ > Ca2+ >Na+ channels (Ovchinnikov 1974, Kamyar et al. 2004). 
Beauvericin from the enniatin group is also a cyclohexadepsipeptide and forms cation 
channels (Kouri et al. 2003) and induce changes in homeostasis, inducing Ca2+ influx in 
mitochondria from pig myocytes as well as decreasing the intracellular ratio of K+ to Na+
(Kouri et al. 2005). The enniatin group of cyclohexadepsipeptides show the stereoisomeric 
cyclo(DLDLDL) configuration (see also Chapter 1.4.3). Thus, forming tubular ion 
channels may explain observed channel properties of enniatins. 
Some ionophoric growth promotors and anticoccidal substances are commonly used as 
feed additives. Carboxylic Ca2+, Mg2+, K+, and Na+ ionophores such as monensin, 
lasalocid, salinomycin, narasin, and laidlomycin produced by Streptomyces species,
maduramycin produced by Actinomadura yumaensis, and semduramicin from 
Actinomadura roseorufa are used as growth promotors or to prevent coccidiosis caused by 
Eimeria in animals (horse, cattle, sheep, and poultry) (Butaye et al. 2003). However, the 
use of ionophores as feed additives has caused several accidental cases of poisoning 
among pets and domestic animals (Van der Linde-Sipman et al. 1999). Narasin from eggs 
is shown heat-stable (Rokka et al. 2005). Recently, it was shown that ionophoric animal 
food additives may act as mitochondriotoxins (Hoornstra et al. 2003). Lasalocid 
transported biogenic amines across the lipid bilayer membrane when studied using the 
BLM technique (Kinsel et al. 1982a,b). The indoor air-isolated Trichoderma harzanium
produced the peptaibol peptide, which formed potassium channels, inhibited motility, and 
depolarized mitochondria of sperm cells (Peltola et al. 2004). Mitochondrial dysfunctions 
affect especially those organs rich in mitochondria, such as the central nervous system, 
liver, lung, kidney, and the heart. 
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1.6. Synergistic effects of Bacillus toxins 
Several Bacillus strains produce toxic compounds that together, in some cases, act more 
efficiently than when alone. Coproduction of iturin and/or surfactin and/or fengycin in the 
same Bacillus strains is common. Surfactins are found as coproducts with iturin or 
plipastatins from B. subtilis (Sandrin et al. 1990, Roongsawang et al. 2002). The non-
peptides zwittermicin A (XVI in Fig. 1) and kanosamine (XVII in Fig. 1) purified from B.
cereus were active against several gram-positive and gram-negative bacteria, were 
fungicidal, and together showed synergistic effects on microbes (Milner et al. 1996, Silo-
Suh et al. 1998). Combination of the antifungal agents LI-F (VIII in Fig. 1) and azole 
acted synergistically against fungi (Kuroda et al. 2000). Sensitivity to the ionophores 
valinomycin (Fig. 4) and A23187 of Escherichia coli was increased 50 - 100 times by the 
presence of polymyxin B (VII in Fig. 1) (Alatossava et al. 1985). Bacillomycin D (Table 
1) and fengycin (Fig. 3) act in a synergistic manner against fungi (Koumoutsi et al. 2004). 
Surfactin (Fig. 2) also acts synergistically with iturin A (Table 1) against fungi (Maget-
Dana et al. 1992, Thimon et al. 1992). Iturin and surfactin interact and increase strongly in 
hemolytic activity compared with their individual effects (Maget-Dana et al. 1992, 
Thimon et al. 1992). Iturin A and surfactin synergy was explained as resulting from a 
mixed micelle formation (Thimon et al. 1992). The synergistic effects of toxins from 
Bacillus species (from coproduction in one strain or in separate strains) should be 
considered when estimating the biotoxin hazards in food or indoor environments. 
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2. Aims of the present study 
This study focused on the non-protein heat-stable toxins produced by bacilli isolated from 
food, food poisoning cases and moisture-damaged buildings in which the inhabitants 
suffered from ill health associated with the indoor environment. 
What are the physical, chemical, and biological properties of such Bacillus toxins? 
To address this topic the following tasks were executed: 
• Purification and characterization of toxins, 
• Investigation of toxicity to different mammalian cells and cell lines, 
• Explaining the biological effects of the toxins, 
• Developing detection and quantitation methods for the toxins.
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3. Material and methods 
3.1. Origins of the toxic Bacillus strains
We examined the toxic B. cereus strains F4810/72, NC7401, and F5881 (I-II) and the B.
licheniformis strains 553/1, 553/2, and 575U/5 associated with food poisoning cases (III). 
Five fungicidal and boar sperm-toxic B. amyloliquefaciens strains (1/117, 2/117, 5/117, 
2.14, 19b) were isolated from water-damaged building material and indoor dust (IV, V). 
The reference strains used were from similar sources or from different culture collections 
(I-V).
3.2. Evaluation of the toxicity of the Bacillus strains using 
eukaryotic cells 
The tools used for the detection of toxic Bacillus strains included inhibition of boar sperm 
cell motility and/or antagonism toward fungal growth on agar plates. The boar sperm cells 
consist of a head, midpiece, and flagellum. The midpiece is crowded with mitochondria 
that produce ATP to move the sperm cell by its propelling flagellum. Toxicity to exposed 
boar sperm cells can be observed as a loss of motility. This is done with the light 
microscope by estimating the exposure dose (ED50) that converts 50% of the cells to a 
non-motile state.
The changes in membrane potentials of the cell and mitochondrial membranes were 
studied using functional fluorochrome stains. Damage of to the plasma membrane was 
recorded using the vital stains calcein acetoxymethyl (AM) ester and propidium iodide 
(III), rhodamine 123 and ethidium bromide (III). Decreases of mitochondrial membrane 
potential were assessed using JC-1 stain (IV, V).
3.4. Purification of toxins 
Methanol was selected as the extractant for active compounds from the biomasses 
obtained from plate-cultivated Bacillus. Further purification of toxins from the methanol 
extract was obtained using solid-phase Sep-Pak C18 cartridges and RP-HPLC. The RP-
HPLC fractions were evaporated and redissolved in methanol before performing the boar 
sperm motility inhibition test.
The RP-HPLC was used as the main tool for purification, amino acid analysis, and the MS 
studies of the toxins. Prior to the RP-HPLC purifications the bacterial methanol extracts 
were fractioned with solid-phase Sep-Pak C18 cartridges to pre-purify or to concentrate the 
toxin. The columns used for RP-HPLC were C8 and C18 phases with eluent compositions 
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of methanol/water with 0.1% formic acid and acetonitrile (0.1% trifluoroacetic acid)/water 
(0.075% trifluoroacetic acid). 
3.4. BLM 
In BLM method artificial membranes from phospholipids or purified cell membranes are 
formed to simulate biological membranes. With BLM it is possible to measure changes in 
lipid film conductance using electrodes. For this bilayer membranes are created in the 
pinhole of the BLM cuvette containing the electrolytic solution and then the test 
substances are added to the cuvette (II). BLM is used to resolve the ionophoretic 
properties of compounds: the selectivity for different anions or cations and to establish 
whether it forms a channel or acts as a carrier. 
Diagram 1 shows a route of the study and the methods. References to the methods used 
are shown in Table 2. 
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Diagram 1. Basic procedures used in this study to investigate the Bacillus toxins. 
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Table 2. List of methods used in this study.
Method References
Identification of the bacteria 
Whole fatty acid analysis                  I-V 
Partial 16S rRNA sequence                I, III, IV 
Automated ribotyping IV 
Microscopy
Photo (epifluorescence)  IV, V 
Confocal (scanning) III 
Electron (transmission) I,II 
Mass and structural analysis 
ESI-IT-MS  IV,V 
MALDI-TOF-MS II 
ESI-TQ-MS I, III 
NMR V 
Amino acid analysis 
RP-LC III 
GC-MS IV 
Purification and quantification 
RP-LC I-V 
Ion conductivity 
Black-lipid membrane (BLM) II,V 
Biological effect 
Boar sperm cells I-V 
Rat liver mitochondria (RLM) II, V 
Feline fetal lung cells IV 
Human neural cells   IV 
Hydrophobicity 
LogKow Program II, this thesis  
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4. Results and discussion 
This study focused on characterizing the non-protein compounds isolated from Bacillus
species implicated in food poisoning and from moisture damaged-buildings in which the 
inhabitants suffered from ill health associated with the indoor environment. Toxic Bacillus
strains were traced, using boar sperm cells as indicators of toxicity. Bacillus extracts toxic 
to boar sperm were fractioned with the RP-HPLC and the toxic fractions were examined  
using MS, NMR and BLM methods and mammalian cells as well as isolated RLM as 
indicators of toxicity. 
Purification, identification, and quantification of the emetic toxin cereulide produced by B.
cereus strains was shown here in a novel bioassay (I), as were the mitochondrial toxicity 
and ionophoretic properties of cereulide (II). Bacillus licheniformis strains isolated from 
food poisoning cases were analyzed for the presence of compounds toxic toward boar 
sperm cells. The biosurfactant lichenysin A was isolated and its biological target in the 
sperm cells was identified (III). A novel toxin named amylosin and the biosurfactant 
surfactin were isolated from B. amyloliquefaciens strains and their properties characterized 
(IV, V). 
The Bacillus toxins studied can be categorized into three groups according their toxicities: 
A. Compounds affecting the mammalian plasma membrane and causing leakage of cell 
contents.
B. Compounds generating ion-selective channels both through the plasma membrane and 
the mitochondria and also causing depletion of cellular ATP and NADH. 
C. Compounds that permeate the plasma membrane without damaging it and affect 
organelles inside the cells such as the mitochondria. 
4.1. Tolerance towards heat, varied pH, and protease of the 
toxins
The enzymes and protein toxins in the Bacillus extracts were deactivated by heating in a 
water bath at 100 °C for 20 min. Boar sperm cells were used as the indicator to detect the 
presence of toxic substances. The toxicity response detected in the extract was scored 
towards treatment with protease, acid (pH 2), and alkali (pH 12). The B. cereus emetic
toxin cereulide was resistant to trypsin, pepsin, and pronase (mixture of carboxypeptidase, 
zinc endopeptidases, aminopeptidases, and serine protease), heating at 121 °C for 15 min, 
pH 2 and pH 12 (I), similar to the result described by Shinagawa et al. (1995). The 
lichenysin A, surfactin, and amylosin were also acid/base-resistant and heat-stable. Cyclic 
compounds are more inert to chemical and physical treatments than related linear 
compounds. Such stable compounds can be expected to be persistant and to remain in the 
environment long after the death of the viable cell that produced them.
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4.2. Purification of the toxins 
4.2.1. Development of the extraction method for the heat-stable Bacillus
toxins
This thesis was the first description of the methods used to purify cereulide from plate- 
cultivated cells of B. cereus, followed by extraction with methanol (I). The methods 
included ammonium acetate precipitation, followed by ethanol and chloroform extraction 
of the precipitate and Sep-Pak C18 cartridge fractionation to purify cereulide from the B.
cereus extract (I). Cereulide purification was improved by leaving out the ammonium 
sulfate precipitation and pre-purifying the methanol extract of plate-cultivated B. cereus
cells directly with Sep-Pak C18 (II). We used methanol as solvent because it possesses 
good penetration properties and dissolves several classes of hydrophilic and hydrophobic 
compounds. Methanol precipitates proteins, which reduces contamination in subsequent 
purification steps. 
In previously publications on purification of cereulide (Agata et al. 1994, Wang et al. 
1995) and homocereulide (Wang et al.1995) time-consuming methods based on liquid 
culture of B. cereus were employed. Agata et al. (1994) precipitated liquid culture with 
ammonium sulfate, extracted precipitate with ethanol, and used various solvent partitions, 
followed by silica gel thin-layer chromatography (TLC) purification and a C18 cartridge. 
Wang (1995) extracted cells of B. cereus with chloroform/methanol, followed by silica gel 
TLC purification.
We found that heat-stable boar sperm-toxic compounds other than cereulide were also 
soluble in 50-100% methanol/water. Solid-phase extraction (SPE) cartridges based on RP 
material such as C8 or C18 were convenient for concentrating and pre-purifying the 
moderate to highly hydrophobic toxins cereulide, surfactin, lichenysin A, and amylosin 
from the Bacillus methanol/water extracts (I-V). Therefore we used the method of plate 
cultivation of Bacillus followed by methanol extraction and Sep-Pak cartridge pre-
purification in all subsequent studies.
Cereulide is soluble in pentane (Häggblom et al. 2002, Jääskeläinen et al. 2003b, Shaheen 
et al. 2006) but the B. amyloliquefaciens toxin amylosin did not dissolve in pentane, 
chloroform, or 100% acetonitrile (IV). Instead of using methanol as we did to extract 
lichenysin A (III) and surfactin (IV) from plate-cultivated Bacillus cells, these compounds 
were purified by acid precipitation (pH 2) from liquid cultures of Bacillus, followed by 
extraction with tetrahydrofuran (Yakimov et al. 1995).
Previously foam fractionation followed by acid precipitation from B. subtilis cultures was 
used to concentrate Bacillus surfactants such as surfactin (Cooper et al. 1981). An 
automated accelerated solvent-extraction (ASE) method, benefitting from pressure, heat, 
and properties of the solvent mixture, may be used for fast-extraction procedures to mine 
toxins from complex matrices such as foods (Jääskeläinen et al. 2003b). Due to the closed 
46
system as an ASE method, personal exposure to the toxins is reduced compared with 
manual extraction. One interesting extraction technique yet to be applied to bacterial 
toxins would be supercritical fluids such as carbon dioxide or pressurized hot water, which 
are non-toxic solvents.
4.2.2. Purifications and quantitation of toxins by RP-HPLC 
Since the hydrophobicity of the toxins studied here (see 4.3) varied from moderate to high, 
the RP-HPLC method was suitable for the purification of these toxins. The RP-HPLC-UV 
methods for purification and quantification of cereulide were developed by us using 
valinomycin (Sigma-Aldrich) as the standard compound (I, II). To date, cereulide is not 
available commercially. The same methods were subsequently used by us to purify and 
quantify valinomycin produced by Streptomyces griseus strains isolated from indoor air 
(Andersson et al. 1998). In these methods acetonitrile/water with trifluoroacetic acid was 
used as the eluent in RP-HPLC and C8 and C18 columns. Later we purified and quantified 
cereulide using methanol/water with formic acid, which is less hazardous than 
acetonitrile/water with trifluoroacetic acid, but comparably efficient (Teplova et al. 2006). 
Both cereulide and valinomycin exhibit activity in RP-HPLC in similar way and 
valinomycin was an excellent reference compound for cereulide analysis. Agata et al. 
(1994) used a C18 column and 95% methanol with trifluoroacetic acid as eluent and Wang 
et al. (1995) used C18 and methanol as eluent in cereulide analysis. However, in these 
studies valinomycin was not used to quantify cereulide. 
The limit for reliable detection of cereulide and valinomycin in the RP-HPLC-UV method 
was rather high, 5-10 μg per injection, because of the UV absorbances (215 nm) of these 
compounds are low. For this reason, a step for the concentration and pre-purifications by 
Sep-Pak Cartridges of the methanol extracts obtained from the bacteria was needed. 
Currently, valinomycin is offered commercially (Sigma-Aldrich, product numbers V0627, 
94675 and V3639) and the company referees to our work (Andersson et al. 1998).
In the present thesis lichenysin A was purified with RP-HPLC from methanol extracts of 
B. licheniformis, using acetonitrile/water with trifluoroacetic acid and a C8 column. 
Commercial surfactin, structurally similar to lichenysin A, was used as a standard 
compound to quantify lichenysin A from the methanol extracts of B. licheniformis (III). 
Developing the HPLC method using methanol/water with formic acid and an analytical 
and semi-preparative C2/C18 column (C18 in V) for toxins from B. amyloliquefaciens
strains resulted protocols in which two toxins, amylosin and surfactin, could be purified 
within a single run (IV, V). The exact concentration of amylosin in methanol solution was 
determined using the ERETIC NMR method (V). Amylosin and the macrolactone polyene 
amphotericin B (924 Da) showed similar UV absorption at 382 nm in concentrations of 1 
μg per injection. This made it possible to develop an analytical RP-HPLC-UV method to 
quantify the novel toxin, amylosin (V). 
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Analytical methods resembling those used by us have been used for the detection and 
purification of other ionophores and metabolites from Bacillus species. The RP-HPLC-MS 
method for quantifying cereulide was developed by Häggblom et al. (2002) using 
valinomycin as standard and RP-HPLC conditions similar to those used by us (II). Cyclic 
fusaricins were isolated from cultures of Paenibacillus polymyxa, extracted with methanol, 
and purified with size-exclusion chromatography, a Sep-Pak C18 cartridge, and HPLC 
(Beatty and Jensen 2002). Liquid chromatography-MS detection and fluoroimmunoassay 
were used to analyze the residues of carboxylic ionophores from eggs and animal tissues 
intended for human consumption (Crooks et al. 1998, Kennedy et al. 1998, Matabudul et 
al. 2000, 2002, Turnipseed et al. 2001). The LC-MS/MS methods were validated to 
analyze residues of coccidiostats such as lasalocid, monensin, salinomycin, and narasin 
from eggs and broilers (Rokka and Peltonen 2006). Following C18 cartridge purification 
heat-stable toxins resembling cereulide in hydrophobicity were found in B. firmus, B. 
megaterium, B. simplex, and B. licheniformis (Taylor et al. 2005). In their study toxicity 
was detected using MTT method and Hep-2 cell vacuolation. The toxins from B.
megaterium and B. licheniformis did not form vacuoles in Hep-2 cells as does cereulide 
(Taylor et al. 2005). 
4.3. Hydrophobicity of the heat-stable toxins isolated from 
Bacillus
4.3.1. Significance of hydrophobicity 
Passive penetration and the potential for bioaccumulation in tissue of any substance 
through the plasma membrane is dependent on the hydrophobicity of the substance.  It is 
well known that hydrophobic xenobiotic compounds such as DDT (Table 3) and PCB can 
bioaccumulate in the fatty tissue of animals and humans. Thus, exposure to persistent, 
toxic hydrophobic compounds at concentrations that are too low to induce acute 
intoxication may much later leave the tissue under certain conditions. Metabolites of 
toxins are usually more polar (and less hydrophobic) than the original toxin and may lose 
the ability to accumulate in animal cells and tissues. The logarithm of the octanol/water 
partition coefficient (log Kow) is one of the parameters used in the quantitative structure-
activity relationship (QSAR) method developed for pharmaceutical, biochemical, and 
toxicological purposes (Meylan and Howard 2000). 
Hydrophobicity indices such as log Kow values can be used to estimate the potential for 
membrane penetration and bioaccumulation. A bioaccumulating compound fits the 
following criteria: 5.0 < log Kow < 7.5, which corresponds to a bioconcentration factor 
(BCF) > 5000 (EEC, 1993).
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4.3.2. Methods used for assessment of log Kow
Log Kow values can be estimated by analyzing the octanol/water solubility ratio of the 
compound using RP-HPLC with reference compounds of known log Kow values or by 
calculating from the structure of the compound with computer programs such as LogKow 
(Meylan and Howard 2000). The LogKow program uses the atom/fragment contribution 
(AFC) method in which the log Kow of fragments and the correction factor coefficients 
were derived by multiple regression from a large database of compounds with 
experimentally determined log Kow values (Meylan and Howard 2000). Estimation of 10 
589 compounds with the LogKow program resulted in a high correlation coefficient (r2  = 
0.943) compared with the experimental log Kow values (Meylan and Howard 2000). The 
structure of the compound is introduced into the LogKow program in the form of SMILES 
(simplified molecular input line entry system) notation. After calculation of the log Kow
fragments of the compound, the results are tabulated and the log Kow of the compound is 
estimated. The LogKow program is allowed for use of log Kow estimation of lubricants for 
the purpose of award eco-label (EU, 2005).
RP-HPLC can be used to determine the log Kow, using methanol/water (or other solvent 
miscible with water) as the eluent and hydrophobic alkyl chains (C2-C18) bonded to silica 
columns as the stationary phase, and using reference compounds for calibration (ASTM 
1992, Saski et al. 1997, Kolari et al. 1998,).











































O-Val Val O-Leu Ala        O-Ala Val O-Val Val
Figure 7. The structures of cereulide (L-O-Val-L-Val-D-O-Leu-D-Ala)3 (1) and valinomycin 
(L-O-Ala-L-Val-D-O-Val-D-Val)3 (2). The hydrophobic side chains of the amino and hydroxy
 acids form the lipophilic outer layers of cereulide and valinomycin, respectively.
O-Leu is 2-hydroxyisocaproic acid, O-Val is 2-hydroxyisovaleric acid, and O-Ala is lactic acid. 
1 2
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Cereulide and valinomycin consist of three repeating units that can be arranged as shown 
by 1, 2, and 3 in Fig. 7. Cereulide and valinomycin have identical backbones and the 42- 
Da difference in the molecular masses is due to the side chains of the outer layers, in 
which cereulide has three D-O-Leu (magenta) instead of three D-O-Val (magenta) in 
valinomycin. Thus, cereulide (log Kow 7.49, Table 3) has three times more CH2 units than 
valinomycin in its outer layer. Translated into log Kow values, this means 1.5 (one 
methylene CH2 corresponds to 0.5 log Kow units in the LogKow program) and 
valinomycin log Kow is 5.99 (Table 3). The LogKow program version 1.57 calculated for 
cereulide and valinomycin a correction factor for the three fragments (-C(=O)-O-C-
C(=O)-N-) whose coefficient is 0.5 (total 1.5); this calculation was missing in program 
version 1.66. Despite the different numerical values obtained for cereulide and 
valinomycin, the difference in log Kow values between valinomycin and cereulide was in 
both cases 1.5 log units (corresponding to a difference of the 31 times of the Kow values) in 
both LogKow program versions. 
Table 3. Log Kow values of the toxins studied and of selected reference compounds. 
Substance Log Kow References
Amylosin 3-4 This thesis, HPLC estimation 
Surfactin C15: 5.55, C14: 5.05, C13: 
4.55, C12: 4.05 
This thesis, calculated 
Lichenysin A C15: 4.89, C14: 4.39, C13: 
3.89, C12: 3.39 
This thesis, calculated 
Cereulide  7.46 (5.96) II, (Teplova et al. 2006), 
calculated
Valinomycin 5.99 (4.49) II, (Teplova et al. 2006), 
calculated
Amphotericin B 2.46 Zhao et al. 2001, calculated 
DTT 1,1,1-trichloro-2,2-di(4-
chlorophenyl)ethane
6.3 Lintelmann et al. 2003 
Benzo(a)pyrene 6.13 Lintelmann et al. 2003 
Values in parentheses are calculated using LogKow program version 1.66 (Teplova et al. 2006). 
Despite the similarity in chemical structures of valinomycin and cereulide, cereulide 
provoked emesis in model animals (Suncus murinus) 60 times more effectively than did 
valinomycin (Agata et al. 1995). Cereulide is more potent as a K+ ionophore at 
physiological K+ concentrations (Teplova et al. 2006). The cereulide toxicity threshold 
(0.5 ng/ml) toward boar sperm cells was four times lower than that of valinomycin (2 
ng/ml) (I). These differences between the biological effects cereulide and of valinomycin 
may be due to the fact that cereulide has a 31-times higher Kow value than valinomycin: 
the calculated log Kow of cereulide is 7.46 and that of valinomycin 5.99 (II, LogKow 
version 1.57).
Due the varying hydrocarbon length and branching of the fatty acid chain of lichenysin A 
and surfactin molecules (from C12 to C17) the log Kow values of these compounds are 
also different. In Table 3 the log Kow values are calculated from iso-C12 to iso-C15 fatty 
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acid-containing lichenysin A and surfactin (iso-C15 fatty acid-containing surfactin and 
lichenysin A are the main parts of these compounds).
The log Kow of amylosin (Table 3) was estimated with RP-HPLC (using a C18 column 
and methanol/water with formic acid as eluent) and including surfactin and amphotericin 
B (4.2.2.2) as references. Since the amylosin retention time was higher than that of 
amphotericin B (log Kow 2.46) and lower than that of surfactin-containing iso-C12 fatty 
acid (log Kow 4.05), the amylosin log Kow was estimated to be between 3 and 4. 
4.4. Amino acid analysis of the toxins 
The amino acid analysis was carried out with RP-HPLC-UV or alternatively with GC-MS 
from hydrolysates of purified peptides. Using Marfey reagent the stereoisomeric forms of 
the amino acid residues L-Gln, L-Leu, D-Leu, L-Val, L-Asp, D-Leu and L-Ile of 
lichenysin A were analyzed with RP-HPLC as diastereomeric 2,4-dinitrophenyl-5-L-
alaninamide derivatives (III). 
The usefulness of the GC-MS method in amino acid residue analysis was noted when the 
B. amyloliquefaciens toxins surfactin and amylosin amino acid residues were analyzed as 
tert-butyl dimethylsilyl derivatives (IV). The amino acid residue composition of amylosin 
(Leu, Pro, Ser, Asp/Asn, Glu/Gln, and Tyr) resembles those found in lipopeptides 
belonging to the ituric group, such as iturins, bacillomycins, as well as fengycin (see pp. 
22-24). However, none of these had a chromophoric group such as that found in amylosin.
The advantage of using GC-MS compared with HPLC-UV is that the HPLC-UV method 
relies only on the retention time, whereas in the GC-MS method verification of the amino 
acids is possible using both the retention time and the mass spectra of the derivatized 
amino acids. The GC-MS method using a chiral column would also give stereoisomeric 
information on the amino acids (Zampolli et al. 2006). LC-MS/MS methods have been 
developed to analyze underivatized amino acids (Qu et al. 2002, Piraud et al. 2005) and 
the micro-LC-MS method for stereoisomers analysis of underivatized amino acids (Zeleke 
et al. 2006). 
4.5. Mass spectrometry of the toxins
ESI-TQ, ESI-IT, and MALDI-TOF MSs were used to characterize and identify the toxins.
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4.5.1. Selective ion complexes of ionophoric toxins in MS and MS/MS 
analysis
We showed that cereulide forms cationized molecules not only with K+ and Na+ but also 
with NH4+ (I, II). This was done using ESI-TQ and MALDI-TOF MS. The interpreted 
ESI-TQ-MS/MS spectrum of cereulide was first published in 1998 (I, Fig. 2B, and Table 
1) using the protonated molecule [M+H]+ of cereulide with a m/z of 1154 as precursor ion. 
In these studies valinomycin was used as the reference compound. Cereulide (C) and 
valinomycin (V) formed protonated molecules [C+H]+ m/z 1154, [V+H]+ m/z 1112, 
cationized molecules [C+NH4]+ m/z 1171, [V+NH4]+ m/z 1129, [C+Na]+ m/z 1176, 
[V+Na]+ m/z 1134, [C+K]+ m/z 1192, and [V+K]+ m/z 1150 in the ESI-MS experiments (I, 
II, and Andersson et al. 1998, Fig. 2A). We showed that cereulide forms a 1:1 complex 
with K+ using BLM data (II). 
Suwan et al. (1995) were the first to show that cereulide forms a complex with the alkali 
metals base in the NMR data. However, these authors concluded incorrectly that cereulide 
forms an ion-dipole with the carbonyl oxygen of amino acids residues D-Ala and L-Val.
This was unfortunate since their NMR studies and comparison of their results with many 
NMR studies of valinomycin such as that of Haynes et al. (1969) showed that ion-dipole 
bonds are formed between cations as K+ and the six carbonyl oxygens of the oxy acids. 
The hexagonal cylinder-like structure of cereulide is similar to that of valinomycin. NMR 
studies of cereulide have confirmed its similarity to valinomycin in the mode of binding 
cations (Pitchayawasin et al. 2003). However in that study there was no direct mention of 
ion-dipole interaction between the cation and the carbonyl oxygen of D-O-Leu and L-O-
Val. Thus, it would be more correct to state that K+ is hosted inside cereulide by the ion-
dipole interactions of three carbonyl oxygens of the D-O-Leu residues on one side of the 
plane and three carbonyl oxygens of the L-O-Val residues on the other side of the plane. 
Later the complexation of cereulide with alkali metal and ammonium ions was confirmed 
by the MS and NMR studies of Pitchayawasin et al. (2003). In 1H-NMR using CDCl3,
studies of valinomycin and cereulide showed similar tendencies in the proton shifts of NH 
and alpha protons complexing with K+, compared with the 1H-NMR shift of the 
uncomplexed state or the proton complex (Haynes et al. 1969, Fig. 1, Pitchayawasin et al. 
2003, Fig. 4). Thus, formations of these complexes showed equal molecular 
conformational changes in valinomycin and in cereulide as observed in NMR. 
The ionic radii of ammonium and potassium are similar; thus cereulide and valinomycin 
complex these ions similarly. Adding volatile ammonium salt (which is more suitable than 
potassium salt for the mass spectrometry instrument) prior to the ESI-TQ-MS analysis 
(valinomycin was dissolved in 50% methanol containing 5 mM ammonium acetate) 
increased the intensity of the ammonium-cationized molecule of valinomycin at m/z 1129
(Andersson et al. 1998, Fig. 2). 
Similar enchancement of cereulide intensity with ESI-TQ-MS analysis was shown for the 
ammonium-cationized molecule of cereulide at m/z 1170 (Paananen et al. 2002, Fig. 1). 
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The abundant ammonium-cationized molecule of cereulide at m/z 1171 was also noted 
when cereulide was purified using the method of protein precipitation with ammonium 
acetate before the MS analysis (I, Fig. 1A). When cereulide was analyzed using MALDI-
TOF-MS (Fig. 2 in II) without adding excess ammonium, the relative abundance of the 
ammonium-cationized molecule of cereulide at m/z 1171 was smaller than the sodium- or 
potassium-cationized molecules of cereulide at m/z 1176 and 1192, respectively. For 
identification of a compound it is necessary to perform MS/MS analysis because different 
compounds can have the same mass ions when analyzed in low-resolution MS but rarely 
the same MS/MS spectrum. The ammonium-cationized molecules of cereulide and 
valinomycin are better precursor ions for MS/MS analysis than the corresponding sodium- 
or potassium-cationized molecules. Using ammonium-cationized molecules as precursor 
ions, fragmentation is achieved at a lower energy input and thus results in a clearer 
MS/MS spectrum. The sensitivity of ESI-MS analysis may be increased by adding 
ammonium to the solution, as in valinomycin (Andersson et al. 1998).
With HPLC-MS analysis the fmol level of cereulide can be detected (Häggblom et al. 
2002, Pitchayawasin et al. 2003). The protonated and cationized molecules of cereulide 
and valinomycin originate from the sample or from the solvent used in the analysis. The 
selectivity of cereulide and valinomycin affinities for the ESI-MS for the ions was: 
potassium > ammonium > sodium ions> proton. If the ionic concentration varies from 
sample to samples, it may cause problems with calculations of the results of the 
quantitative analysis since both the protonated and cationized molecule peak areas should 
be integrated. We conclude that adding an excess amount of ammonium acetate to the 
standards and to the samples or eluent is an advantage in LC-MS analysis, beause it would 
set the ionic conditions in the standards and the samples at equal levels. Detecting very 
low concentrations of cereulide from cells or tissues may be important for biochemical or 
medical purposes. Since the peak concentration in HPLC is inversely proportional to the 
square of the column radius, micro- and nano-LC columns can also be used to increase 
sensitivity (Kostiainen et al. 2003). 
Two homologs, 1138 Da and 1166 Da, of cereulide were reported by Pitchayawasin et al. 
(2004) and 1166-Da homocereulide (see also pp. 32, 34) was also reported by Wang et al. 
(1995). Since the differences are ±14 Da and cereulide (1152 Da) consists of a three-
repeating unit, this is no more the case with homologs that have two repeating units and 
one modified unit. Pitchayawasin et al. (2004) proposed that in the 1166-Da homolog of 
cereulide (1152 Da) O-Val was changed to O-Leu and in the 1138-Da homolog O-Leu to 
O-Val. Since the amounts of these homologs were 10% of the total cereulide (1152 Da) 
produced, this may not affect the toxicity. However, some strains or growth conditions of 
B. cereus could produce a higher amount (over 10% of the total cereulide) of such 
homologs, which should be considered in the RP-HPLC-MS analysis. The homologs may 
possess affinity for K+ different from that of cereulide, due to their minor structural 
difference. It was shown that cereulide toxicity is based on its extremely high affinity for 
K+ (Teplova et al. 2006). 
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4.5.2. Mass spectrometric characteristics of the lipopeptide toxins and 
amylosin
Membrane-destroying substances from B. licheniformis and B. amyloliquefaciens were 
identified as lichenysin A and surfactin, respectively, with MS and MS/MS analysis using 
MALDI-TOF, ESI-TQ and ESI-IT MS (III, IV). Identification of lipopeptides having a 1-
Da difference in their masses (or even having an equal mass number) with MS analysis is 
not specific enough, considering inaccuracy in mass detection (typically up to 0.50 Da in 
low-resolution mass spectrometers). Such lipopeptide identification requires MS/MS 
analysis and/or use of reference compounds. The amino acids sequence of lichenysin A 
was interpreted from ESI-TQ MS/MS data (III), while that of surfactin (from B.
amyloliquefaciens 19b) was identified by comparing its ESI-IT-MS/MS spectrum with the 
MS/MS spectra of commercial surfactin (Sigma-Aldrich). Surfactin and lichenysin A 
formed three peaks each in UV absorption at 215 nm in the HPLC elution profiles (III, 
Fig. 1 and IV, Fig. 2) and the MS total ion chromatograms (IV, Fig. 2). The different 
peaks were due to the carbon chain lengths of tridecanoic, tetradecanoic and 
pentadecanoic 3-hydroxylated fatty acids of these lipopeptides. These lipopeptides, 
containing 3-hydroxylated fatty acids, formed protonated and potassium- and sodium- 
cationized molecules as shown in the mass spectra of lichenysin A, using MALDI-TOF-
MS (III, Fig. 1). 
The protonated molecules at m/z 995 and 1009 and the corresponding sodium-cationized 
molecules at m/z 1017 and 1031 of surfactin were used as precursor ions in ESI-IT- 
MS/MS analysis (Fig. 8 A and B). The distinctive high abundance of fragment ions at m/z
686 and 708 were observed, using protonated and sodium-cationized molecules of 
surfactin as precursor, respectively. Fragmentation patterns similar to those in Fig. 8 A 
and B were found in all studied MS/MS spectra (containing different carbon chain 
lengths) obtained from protonated and sodium-cationized molecules of surfactin and 
lichenysin A. The abundant protonated molecule at m/z 685 was obtained by Yakimov et 
al. (1999) from an alkaline-hydrolyzed product of lichenysin A and also from the MS/MS 
spectra of native surfactin and lichenysin A when these lipopeptides were analyzed using 
fast-atom bombardment MS. The origin of the MS/MS fragment ions at m/z 686 and 708 
is the opening of molecules between the hydroxy acid Ile in lichenysin A and Leu in 
surfactin and fragmentation between Leu and Gln (lichenysin A) and Glu (surfactin) (see 
also I, II in Fig. 1). The fragment ions at m/z 686 and 708 represent [HN-
LeuLeuValAspLeuIle-COOH+H]+ and [HN-LeuLeuValAspLeuIle-COOH+Na]+ of 
lichenysin A (see also II in Fig. 1) and [HN-LeuLeuValAspLeuLeu-COOH+H]+ and [HN-
LeuLeuValAspLeuLeu-COOH+Na]+ of surfactin (see also I in Fig. 1), respectively.
Thus observation of fragment ions m/z 686 and 708 in the MS/MS spectra of lichenysin A 
and surfactin can be used for identification of these lipopeptides The mass spectrum of 
surfactin from B. amyloliquefaciens 19b (Fig. 8C) observed in the negative mode shows a 
monoisotopic distribution of deprotonated molecules at m/z 1007, 1021, and 1035. The 
protonated molecules of lichenysin A at m/z 1007, 1021, and 1035 and the corresponding 
sodium-cationized molecules at m/z 1029, 1043, and 1057 and the potassium-cationized 
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molecules at m/z 1045, 1059, and 1073 are shown in the MALDI-TOF-MS spectra of 
lichenysin A (Fig. 1 in III). The MS and MS/MS spectral data as described above and the 
use of negative-mode MS are tools that can be used for identifying lichenysin A, surfactin, 
and other similar cyclic lipopeptides.
The MS and MS/MS data were used for identification of fengycin A and B (see 1.4.1.3.) 
produced by B. amyloliquefaciens 19B. The protonated molecules of fengycin A β-OH-
FA(C15) at m/z 1450, β-OH-FA(C16) at m/z 1463, and β-OH-FA(C18) at m/z 1493 and of 
fengycin B and β-OH-FA(C17) at m/z 1506 and the sodium-cationized molecules of 
fengycin A β-OH-FA(C16) at m/z 1484 and β-OH-FA(C17) at m/z 1500 and of fengycin B 
β-OH-FA(C17) at m/z 1528 were observed from B. amyloliquefaciens 19B using LC-ESI-
IT-MS (Fig. 9A). These observed mass ions corresponded to published MS data on 
fengycin A and B (Vater et al. 2002, Madonna et al. 2003, Hofemeister et al. 2004, Kim et 
al. 2004, Koumoutsi et al. 2004, Wang et al. 2004).
The MS/MS fragmentation of the protonated molecule at m/z 1492 (Fig. 9B) provided the 
fragment ions at m/z 967 and 1080, while the protonated molecule of m/z 1506 (Fig. 9C) 
provided the fragment ions at m/z 995 and 1108. The origin of the MS/MS fragment ions 
at m/z 967 and 1080 (fengycin A) and m/z 995 and 1108 (fengycin B) is fragmentation of 
the fengycin A and  B protonated molecules between Orn and Tyr (product ions m/z 967 
and 995) or Glu and Orn (product ions m/z 1080 and 1108) (see XII in Fig. 1). Thus, the 
fragment ions represent [cyclo(Ile-Tyr-Gln-Pro-Ala/Val-Glu-Thr-Tyr)-Orn+H]+ and 
[cyclo(Ile-Tyr-Gln-Pro-Ala/Val-Glu-Thr-Tyr)+H]+ of fengycin A and B. The calculated 
monoisotopic masses of the fragment ions were m/z 1080.5 (Ala, fengycin A), m/z 1108.6
(Val, fengycin B), m/z 966.5 (Ala, fengycin A), and m/z 994.4 (Val, fengycin B), 
respectively. These MS/MS results are consistent with previously published MS/MS data 
on fengycin (Madonna et al. 2003, Wang et al. 2004). The MS and MS/MS analyses 
suggest that B. amyloliquefaciens 19B produced lipopeptides fengycin A and B. 
When the sperm-toxic fraction of B. amyloliquefaciens 19B methanol extract was 
analyzed with HPLC-ESI-IT-MS (Fig. 2B, C in IV) or using a syringe pump to inject the 
sperm-toxic fraction into the ESI-IT-MS (Fig. 1C, V), the mass ion at m/z 1220 was 
observed in the positive-ionization mode. The MS technique can be used to determine 
compound monoisotopic molecular masses during positive- and negative-ionization 
experiments. In the MS analysis of amylosin the deprotonated molecule at m/z 1196 (IV 
and Fig. 1 D in V) was obtained in the negative-ionization mode and therefore the mass 
ion at m/z 1220 was assumed to represent the sodium-cationized molecule of amylosin. 
Thus, the monoisotopic molecular mass of the toxic compound was set at 1197 Da. 
Therefore, B. amyloliquefaciens strain 19B produced at least the lipopeptides surfactin and 



























































































































































































































































































































































































































Figure 8. ESI-IT-MS and MS/MS spectra of surfactin isolated from B. amyloliquefaciens strain 
19B. (A) MS/MS using the protonated molecule at m/z 995 (upper panel) and sodium-cationized 
molecule at m/z 1017 (lower panel) as precursor ions (B) MS/MS using the protonated molecule at 
m/z 1009 (upper panel) and sodium-cationized molecule at m/z 1031 (lower panel) as precursor 
ions (C) Deprotonated molecules of surfactin obtained in the negative-ion mode MS.
The toxins of B. cereus, B. licheniformis, and B. amyloliquefaciens investigated here had 
masses of from 1000 to 1200 Da. This range is similar to that of most toxic substances 
from the Bacillus species represented in Table 1. This size of toxic cyclic peptides may 
possess enough functional groups to initiate bioactivity as well as having hydrophobicity 
high enough to passively permeate the cell membranes. 
MALDI-TOF-MS can be used for analyzing products of microbial metabolism and for 
direct detection of compounds of known toxicity as well as for solving taxonomic 
problems. Easy sample preparation and recent developments in small benchtop MALDI-
TOF-MS instruments have made this an attractive technique for microbial toxin analysis. 
The MS data on heat-stable Bacillus toxins and valinomycin from Streptomyces griseus,












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.6. NMR analysis of amylosin 
The structural properties of amylosin were determined using NMR (V). The HPLC-SPE-
NMR technique (the single peaks of amylosin from several HPLC runs were pooled in the 
SPE cartridge and later released to the NMR tube) with a 500-MHz NMR spectrometer 
equipped with a 5-mm probe (Bruker Biospin, Rheinstetten, Germany) was used to obtain 
the 1H-NMR spectrum of amylosin. This 1H-NMR spectrum of the HPLC-purified 
amylosin was used as a reference in the NMR experiments performed with a 600-MHz 
NMR spectrometer equipped with a TXI 1-mm MicroProbe (Bruker Biospin, Fällanden, 
Switzerland). With a 1-mm probe it was possible to carry out several NMR experiments at 
a concentration of 66 mM using small amount (400 µg) of the amylosin (V).  
The data of the NMR experiments, using 1H-NMR, HSQS, and COSY, and the simulated 
1H-NMR spectrum using the Perch program (PERCH Solutions Ltd, Kuopio, Finland) 
showed that amylosin contained a polyene structure with a conjugated double-bond 
system of hexaene. The conjugated chromophore system of amylosin resembles that found 
in polyene macrolides (Fig. 1 in V). The TOCSY and HSQC data showed that amylosin 
contained the amino acids: Glu/Gln, Asp/Asn, Leu/Ile, Tyr, and Pro (V, Fig. 2) and 
supported the results obtained with GC-MS amino acids analysis (IV, p. 319) expect that 
Ser was not found in NMR (see 4.4). The ERETIC NMR method was used in quantitation 
of amylosin (see 4.2.2). This NMR methodology has been used in pharmaceutical 
applications (Pan et al. 2006). 
The polyene macrolides are fungicidal substances that intercorporate with ergosterol to 
form channels or pores in the cell membrane of fungi. Medical use of polyene macrolides 
is limited because they are also active in cholesterol-containing membranes i.e. they are 
potentially toxic to animal and human cells. Amphotericin B is a fungicidal cyclic 
compound produced by Streptomyces. It has an amphoteric structure with hydrophilic 
hydroxyl groups on one side of the molecule and a hydrophobic polyene structure on the 
other side. It binds to the fungal ergosterols and distrupts the fungal cell membrane, 
causing leakage of cell components, and is also nephrotoxic (Goldman and Koren 2004). 
Compounds having polyene structure are known to be produced by Bacillus species. 
Cytotoxic macrolactin A (XX in Fig. 1), isolated from Bacillus species (Gustafsson et al. 
1989), has 12 olefinic methine carbons. It disrupted the mycelia of Streptomyces scabies
by a mechanism resembling that of polyene macrolides (Han et al. 2005). Thus, 
macrolactin A may have potential pore-forming properties. Antibacterial difficidin and 
oxydifficidin, which contain diene and triene structures, and 7-O-macrolactin which has 
polyene structures, are cyclic macrolides produced by B. subtilis (Hofemeister et al. 2004). 
It is interesting that the bacteriostatic compound bacillaene (580 Da) isolated from B.
subtilis (bacillaene structure was partially characterized) contained a hexaene structure 
whose 1H-NMR spectrum in the polyene range resembles that of amylosin (Patel et al. 
1995).
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Pigments protect some Bacillus strains from UV radiation as in B. atrophaeus DSM 675, 
whose spores contain a red pigment resembling carotene (Moeller et al. 2005). Therefore, 
amylosin may also play a role in protecting B. amyloliquefaciens against UV radiation. 
4.7. Detection methods for cereulide and cereulide-producing 
strains of B. cereus 
Several methods have been described in the literature to detect cereulide and cereulide-
producing strains of B. cereus. Dilution methods such as Hep-2 cell vacuolation titer are 
suitable for semiquantitatively comparing toxicity but too imprecise for detecting the exact 
concentration of cereulide. Tests in which the detection of toxicity is based on light 
microscopy for observing changes in cells exposed to toxin may also suffer from person-
related factors. The mitochondrial uncoupling properties of cereulide have been used to 
develop a quantitative method for detecting cereulide using RLM (Kawamura-Sato et al. 
2005); however such a method can also detect other ionophoric toxins in food, such as 
coccidiostats (see p. 32). 
The fastest and most specific method for detecting cereulide in food is the RP-HPLC-MS 
method in which the retention time, MS spectra, and MS/MS spectra can be used to 
identify and quantify cereulide. MALDI-TOF-MS can also be used to identify cereulide 
from bacterial extracts (II, Fig. 2). The RP-HPLC-UV method is suitable for detecting 
cereulide in cell extracts of B. cereus strains. 
Basically, the same toxicity detection methods can be used for species of Bacillus other 
than those producing cereulide (Beattie and Williams 1999, Pedersen et al.2002, From et 
al. 2005,  Hsieh et al. 2004). Using small-acid soluble proteins of Bacillus spores as 
biomarkers and analyzing the cell extracts with MALDI-TOF-MS may support 
identification of Bacillus species and toxins (Hathout et al. 2003). 
In comparing the toxicity of various strains affecting target cells in the same manner, two 
situations related to toxicity must be considered: either the toxins are the same or they are 
different. In the first case different strains can produce the same toxin in varying amounts 
under equal conditions. On the other hand, one toxin can be more powerful but produced 
in smaller amounts than the other. 
Detecting the existence (past or present) of strains potentially able to produce cereulide 
can be done with polymerase chain reaction methods, but genetic methods tell nothing 
about the cereulide contents of samples. 
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Oxygen consumption by rat liver 
mitochondria
Kawamura-Sato et al. 2005 
Cytotoxicity assay using Chinese 
hamster ovary cells 
Beattie and Williams 1999, Pedersen et al. 
2002
RP-HPLC-ESI-MS Häggblom et al. 2002 
RP-HPLC-UV, MALDI-TOF-MS   I,II  
Teplova et al. 2006 
Hep-2 cell culture using basic 3-(4,5-
dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide as 
indicator (MTT assay) 
Finlay et al. 1999, Toh et al. 2004, Taylor et 
al. 2005
Hep-2 cell vacuolation, titer method Hughes et al. 1988, Agata et al 1994 
Boar sperm motility test I, II, Andersson et al. 2004 
Detection of cereulide-producing strains of B. cereus
Method Reference
Fourier transform infrared 
spectroscopy
Ehling-Schulz et al. 2005b 
Polymerase chain reaction methods Ehling-Schulz et al. 2004, Horwood et al. 
2004, Nakano et al. 2004,Toh et al. 2004
4.8. Biological properties of the toxins 
4.8.1. Mammalian cells 
Using specific fluorochromic stains it is possible to differentiate between several modes of 
toxicity: live and dead stainings calcein AM ester and ethidium homodimer-1 (I), ethidium 
bromide and rhodamine 123 (III), and PI (IV, V) or the height of transmembrane electric 
potential monitoring stains JC-1 (IV, V) and rhodamine 123 (II). In this way it is possible 
to obtain more specific information on toxin targets inside the cells. 
4.8.1.1. Cereulide 
Cereulide (0.5 ng/ml) inhibited motility and depolarized the mitochondrial membrane in 
the absence of damage to the plasma membrane in boar sperm cells in a manner similar to 
that of valinomycin (2 ng/ml). Cereulide (I, Fig. 1; II, Fig. 1) and valinomycin (Andersson 
et al. 1998, Fig. 1) also swelled the mitochondria of the boar sperm cells. Cereulide was a 
more potent toxin in the boar sperm cells than valinomycin (I, Table 1). The same was 
observed with isolated RLM with these toxins in a medium whose ionic composition 
matched that of blood plasma (Teplova et. al. 2006). Hyperpolarization of the cell 
64
membrane by exposure to valinomycin or cereulide was reported in boar sperm cells 
(Hoornstra et al. 2003). Gramicicin D depolarized and valinomycin hyperpolarized human 
B lymphoblastoid JY cell plasma membranes and endorsed killer activity of T cells (Bacso 
et al. 1996). Exposure of rat hepatocytes to the protonophore gramicidin A, the potassium 
carrier valinomycin, and the calcium carrier ionomycin first increased the sodium contents 
in the cell together with loss of potassium, increased the water content, and finally altered 
the K:Na ratio from 10:1 to 1:1 and affecting the cell morphology (Bolkent and Zierold 
2002). Initiating the apoptosis cascade has also been connected to the depolarization of 
mitochondria.
4.8.1.2. Amylosin 
Amylosin hyperpolarized the plasma membrane and depolarized the mitochondrial 
membrane of boar sperm cells at the same concentrations (30-60 ng/ml) without 
permeabilizing the plasma membrane to propidium iodide (V). The toxic effects of 
amylosin increased with longer exposure times, as shown by the lower hydrophobicity 
(Table 3) of amylosin compared with the other toxins studied. 
4.8.1.3. Surfactin and lichenysin A 
Surfactin from B. amyloliquefaciens and lichenysin A from B. licheniformis were toxic to 
boar sperm cells at concentrations of 4-8 μM. These substances decreased sperm motility, 
disrupted the cell membrane, and provoked an acrosome reaction (III, Fig. 2). The critical 
micelle concentration (CMC) of surfactin is dependent on the ionic strength. The CMC of 
surfactin was 7.5 μM in 100 mM NaCl (Heerklotz and Seelig 2001). The boar sperm MR-
A extender contains 126 mM Na+ (Na+ is a main ion of the extender; IV), which indicates 
that surfactin destabilized the cell membrane of boar sperm at its CMC. This shows that 
the micelles of surfactin and lichenysin A disrupted the plasma membrane; however, it is 
not known whether surfactin or lichenysin A forms micelle aggregates in the medium or 
after embedding into the membrane. With lichenysin A 100% hemolysis of blood was 
observed at 15 µM instead of the 200 µM required for hemolysis by surfactin 
(Grangemard et al. 2001). Surfactin is more anionic at pH 7 (see also Chapter 1.4.1.1, Fig. 
2) because it contains Asp and Glu in contrast to lichenysin A, which contains Asn and 
Glu. This may lead to differential activity in membranes. 
Lipopeptides such as lichenysin A and surfactin are biosurfactants; thus their effect on cell 
membranes as detergents is clear but they also have other biological functions. Surfactin 
and lichenysin belong structurally to lactones known as bioactive compounds. Lactones 
and cyclic peptides blocked the active sites of protease enzymes (Gaczynska and Osmulski 
2005). Indeed, lichenysin A and the structurally similar isohalobacillin inhibited 
cholesterol acyltransferase (Hasumi et al. 1995) as did also the cation channel-forming 
beauvericin (Tomoda et al. 1992). When the effects of surfactin on vesicles made of 
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palmitoyloleylphoshatidylcholine (POPC) was studied, it were found that surfactin 
released the content of vesicles below its CMC (Carrillo et al. 2003).
The toxicity to boar sperm of methanol extracts of B. subtilis FZB42-containing surfactin, 
bacillomycin, and fengycin was low compared with the high toxicity of similarly prepared 
extracts of B. amyloliquefaciens 19B-containing amylosin, surfactin and fengycin. The B.
subtilis FZB42 and B. amyloliquefaciens 19B extracts contained similar amounts of 
lipopeptides. This also indicates that the effects of amylosin are different from those of the 
lipopeptides. Amylosin-producing strains of Bacillus have high mammalian toxicity. Iturin 
and bacillomycin, which belong to the iturinic group (Vater et al. 2002), have low toxicity 
to boar sperm cells. The cholesterol content of boar sperm cells is low (cholesterol/ 
phospholipid molar ratio 0.26, Parks and Lynch 1992) and that in mitochondria virtually 
zero (Colbeau et al. 1971); thus compounds needing cholesterol to form pores, e.g 
fengycin and iturin (see also iturins, Chapter 1.4.1.2), are less active toward boar sperm 
cells than other mammalian cells.
4.8.1.2. Cultured cells 
Exposure of human neural cells (Paju) to amylosin rendered them permeable to PI, 
whereas in boar sperm cells this effect was not detected after similar exposure (IV). Feline 
lung cells died rapidly (IV, V) when exposed to amylosin, possibly due to loss of selective 
membrane permeability to sodium and/or potassium ions and by depletion of cellular ATP 
(one toxicity parameter used when boar sperm cells were exposed to amylosin). The 
depletion of cellular ATP was proposed to be one reason for the irreversible cell injury 
shown when the effects of cyanide, oligomycin, and CCCP in rat hepatocytes were studied 
(Nieminen et al. 1994).
4.8.2. Bacillus toxins that altered functions of the mitochondria 
4.8.2.1. Cereulide 
Potassium carriers such as cereulide were proposed to be specific mitochondriotoxins (II). 
Cereulide toxicity to RLM was studied in detail (II). Cereulide induced mitochondrial 
dysfunctions at low exposure concentrations (0.5 ng/ml) in the presence of potassium ions 
by lowering the mitochondrial membrane potential (I, II). Changes in the membrane 
potential in isolated mitochondria exposed to the toxins were studied, using rhodamine 
123, which is a cationic, water-soluble, lipophilic chloride salt that is taken up by 
mitochondria with membrane potential (negative inside) and monitored as a quenching of 
fluorescence in buffer solution. When the mitochondrial membrane potential decreases, 
rhodamine returns to the buffer and an increase in fluorescence is seen. The potassium 
concentration in the cytosol is higher than that of sodium, while in the blood plasma the 
concentration of sodium is higher than that of potassium.  Thus, using an external medium 
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low in potassium is a physiologically relevant condition. In a sodium medium cereulide 
had only minor effects on the mitochondria (II). Addition of cereulide first increased the 
membrane potential of the mitochondria in a sodium medium, and then decreased it, and 
addition of potassium in this state accelerated decay. Swelling of the mitochondria in 
response to cereulide exposure was shown both in isolated RLM (II, Fig. 5) and in boar 
sperm cells (II, Fig. 1). The mitochondrial inner membrane is folded, containing a high 
surface area (see also Chapter 1.5.1., Fig. 5). Exposure to a potassium ionophore mediates 
potassium intake followed by water diffusion into the matrix and subsequent swelling of 
the mitochondria (II, Fig. 1). Thus, cereulide disrupt the osmotic balance of the 
mitochondria and provokes dysfunctions, e.g. in ATP production. The effect of cereulide 
on mitochondria was similar to that of its structural relative valinomycin. We concluded 
that cereulide is mitochondriotoxic due to its ionophoretic properties (II). 
4.8.2.2. Amylosin 
Exposure to purified amylosin uncoupled isolated RLM, decreased the mitochondrial 
potential, and caused oxidation of the PN and diminished production of ATP (V). These 
mitochondrial dysfunctions were concentration-dependent and potassium- and sodium- 
selective. Using potassium-selective electrodes it was shown that amylosin forms 
potassium-permeant channels in the mitochondria (Fig. 10). Amylosin induced swelling of 
mitochondria in manner similar to that of valinomycin and cereulide. The differencein 
effects between amylosin and cereulide or valinomycin was that the latter were not active 
in sodium media whereas amylosin affected mitochondria in sodium media with half of 
the effectivity seen in potassium media. It was shown that the effects of amylosin in 
mitochondria were not due to the mitochondrial permeability transition pore (PTP) 
opening, but instead were mediated by formation of independent channels.
Amylosin formed individual potassium (sodium, calcium) channels. The mitochondrial 
inner membrane lacks sterols (Colbeau et al. 1971), showing that amylosin is able to form 
channels without interacting with sterols, thus differing from the polyene macrolides. 
Iturin A was also unable (unpublished results) to release potassium from the mitochondria, 
as was expected since it needs sterol to form channels. 
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Figure 10. Isolated rat liver mitochondria were used to study how amylosin affected  
mitochondrial functions. Amylosin induced channels (A) and swelling in mitochondria (B). 
Figures are modified using Figs. 6B and 7A (V). Potassium chloride (KCl) 0.7 mM (A) and 120 
mM (B), +ATP, adenosine 5'-triphosphate is added, 1 mM (A). 
Isolated RLM were used as tools to study the effects of amylosin in membranes. A 
potassium-selective electrode was used to monitor the K+ concentration in the external 
medium when RLM were exposed to amylosin (Fig. 10A). Amylosin forms channels in 
the mitochondrial inner membrane and the positive potassium ions are exported through 
the channels due to electrostatic attraction (see also Chapter 1.5.1, Fig. 6). When the 
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mitochondrial membrane was depolarized with the protonophore uncoupler FCCP the 
flow of potassium ions was reversed (Fig. 10). Amylosin did not affect the natural ATP-
dependent mitochondrial potassium channels and the ion channels formed by amylosin 
were ATP-independent (V, Fig. 6). 
The optical density of the mitochondria suspension of measured at 540 nm was decreased 
when the mitochondria were exposed to amylosin, indicating swelling of the mitochondria 
(Fig. 10, B), which was concentration-dependent. Amylosin also swelled the heads of boar 
sperm cells, showing formation of similar channels in the plasma membrane (V, Fig. 5D). 
The potassium carrier valinomycin was used as a reference. The experiment in Fig. 10A 
was carried out at an amylosin concentration of 200 mM in K+ medium. Amylosin also 
inhibited oxidative phosphorylation both in potassium and in sodium media (V, Fig. 8). 
4.8.3. Ionophoretic properties of toxins analyzed with the black-lipid 
membrane (BLM) technique 
For the BLM studies soybean L- -phosphatidylcholine (Asolectin, type II-S) was used. Its 
approximate composition was: phosphatidylcholine (24%), phosphatidylethanolamine 
(20%), inositol phosphatides (14%), the remainder being other phospholipids, lipids, and 
carbohydrates (Ardhammar et al. 2002).
Agata et al. (1994) proposed that cereulide is a K+ ionophore and Suwan et al. (1995) 
showed in NMR that cereulide forms alkali metal complexes and is a potential potassium 
ionophore. We first suggested that cereulide forms channels (I); however, analyzing it 
with BLM and also isolated RLM showed that cereulide acts as a potassium carrier 
causing swelling and stimulating respiration in the presence of potassium (II).
The ionophoretic properties of cereulide were experimentally determined for the first time 
using BLM (II). Cereulide iniated increase in conductance of the BLM at a concentration 
as low as < 0.2 ng/ml in 100 mM KCl media (II, Fig. 3). We found that the conductance 
provoked by cereulide was cation-selective in a carrier manner and increased 
stoichiometrically with the concentration of cereulide. Cereulide was highly selective for 
potassium ion: it carried potassium three orders of magnitude more effectively than 
sodium ions or protons and two orders of magnitude more effectively than calcium ions. 
The ionophoretic selectivity of cereulide resembles that of valinomycin in BLM. 
Lichenysin A and surfactin were not active in BLM; however, surfactin formed channels 
when glycerol monooleate lipids were used to generate the BLM, but was not active when 
phosphatidyl choline was used (Sheppard et al. 1991). Surfactin formed a cation-selective 
K+ > Na+ channel in glycerol monooleate lipid membrane at a 1M salt concentration. The 
pore-forming properties of surfactin may be due to its ability to form dimers in the 
membranes (Sheppard et al.1991, Carrillo et al. 2003). The activities of iturin and 
surfactin in artificial membranes of glycerol monooleate differ from those observed in 
phosphatidylcholine. Iturin is active in both membranes, whereas surfactin only forms 
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pores in glycerol monooleate. Surfactin also needs to form dimers with salts before it 
enters the membrane and forms pores (Sheppard et al. 1991). 
Interestingly, methanol extracts of B. licheniformis strains 553/1 and BAS50 which 
produce lichenysin A and type strain DSM13 formed K+ channels in BLM. Lichenysin A-
producing strains 553/1 and BAS50 were manyfold more active than B. licheniformis type 
strain DSM13 (Grigoriev et al. unpublished data). Channels generated in the BLM by the 
extract obtained from strain 553/1 were open for a longer time and were more cation- 
selective (anion/cation selectivity 28) than the channels observed using the extract from 
strain BAS50 (anion/cation selectivity 3.8). Purified lichenysin A was not active in the 
BLM. When the B. licheniformis extracts were fractioned with HPLC, the channel-active 
compound(s) was located in the fractions containing polar compounds. In addition, this 
channel-forming substance(s) was non-toxic to boar sperm cells. Further purification and 
properties of this channel-forming substance(s) are still under investigation. Recently it 
was shown that the genome of strain DSM13 contains genes with the potential for 
biotechnological applications (Veith et al. 2004). 
Figure 11. Typical recording for a channel-forming substance observed when amylosin was 
analyzed with BLM. Opening (the conductivity increased for a short time) and closing 
(conductivity returned to the baseline) of single potassium channels are seen here. The amylosin 
concentration was < 20 nM in 1 M KCl medium and the applied voltage was 100 mV. 
Carriers act differently from channel formers in the BLM. The conductivity increases 
when the concentration of carriers increases, whereas channel formers induce jumps in 
conductivity in single-channel experiments (open and closed state of channels). Amylosin 
is two times more effective in forming potassium channels than sodium channels. 
Dependence of conductance for potassium on the concentration of amylosin in BLM is 
seen in Fig. 11. The conductivity for K+ began to increase at a concentration 30 ng/ml (V, 





We concluded that the toxicity of amylosin is due its channel-forming properties. 
Amylosin forms cation-selective channels in the order K+ > Na+ > Ca2+ of 26 > 15 >3.5; 
thus, amylosin was two times more selectively for potassium than for sodium. Gramicidin 
A has a similar selectivity ratio K+ > Na+  of 20.6 > 14.6 in DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine) membrane (Pfeifer et al. 2006), but also formed H+ channels 
whereas amylosin did not. When exposed to 1 μg/ml gramicidin D, NG108-15 
neuroblastoma X glioma hybrid cells lost their capacity to generate action potentials 
(Doebler 1999). Since the balance in Na+ and K+ plays a role in formation of the action 
potential, a channel-forming compound such as amylosin may disturb it. 
Potassium and sodium channel-forming amylosin affects mammalian cells in a mode that 
is different from that of the potassium carriers cereulide and valinomycin, which are 
clearly mitochondrial toxins. The capacity of valinomycin to transport and release 
potassium was estimated as 104 potassium ions per second, whereas the quantity of 
potassium that can pass through channel-forming compounds such as gramicidin A is 
1000 times larger. Amylosin as a channel-forming substance is thus an effective potassium 
and sodium transporter. The properties of heat-stable Bacillus toxins and valinomycin 
from Streptomyces griseus, including their origin, chemical properties, toxicity toward 































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   















































5. Conclusions and remarks 
The results of this study and added with those in the literature showed that Bacillus
species common in food and in the environment, growing under anaerobic and aerobic 
conditions over a broad temperature range produced thermally stabile non-protein 
compounds toxic to mammalian cells. In the present study toxins were found belonging to 
the cyclic lipopeptide, peptide and cyclic depsipeptide chemical groups with MW of 1000-
1500. They were ionophoretic, causing imbalance in the homeotasis of ions in cells, and 
damaging the plasma membrane, causing leakage of the cell contents. Here we showed 
that the ionophoric Bacillus toxins investigated altered the mitochondrial functions of 
mammalian cells. The properties of compounds indicate their environmental toxicity: i.e. 
their persistence, hydrophobicity and toxicity, to mammalian cells. 
5.1. Conclusions 
I. Cereulide, a cyclic depsipeptide (1152 Da), is a food poisoning toxin produced by 
certain strains of B. cereus. Cereulide was purified from B. cereus extracts using RP-
HPLC. Identification of cereulide was performed using MS spectra and we represent the 
first time the interpreted MS/MS spectrum of cereulide (I). The RP-HPLC-UV method 
was developed, in which valinomycin was selected as the standard compound for 
quantifying cereulide.
II. The potassium carrier properties of cereulide were discovered by black lipid membrane 
(BLM) method and were published for first time. The log Kow values of cereulide (7.46) 
and valinomycin (5.99) were calculated. Studies of the effects of cereulide on 
mitochondria and on BLM showed that cereulide is a more potent potassium carrier
ionophore than valinomycin, the most potent natural potassium ionophore previously 
known. We established that the toxicity of cereulide is due to its potassium carrier 
properties.
III. A toxin was found, using boar sperm cells as the indicator, from B. licheniformis
associated with a case of food poisoning. The substance was identified as the lipopeptide 
lichenysin A, using MS and MS/MS data and by stereoisomeric D and L amino acid RP-
HPLC-UV analysis. The toxicity target of lichenysin A is the cell membrane. This toxin 
damaged the cell membrane of boar sperm and provoked the acrosome reaction.
IV. Fungicidal and boar sperm-toxic strains of B. amyloliquefaciens were isolated from a 
moisture-damaged building in which the occupants suffered from respiratory symptoms 
and nervous illness. The toxic substance of these B. amyloliquefaciens strains was purified 
with RP-HPLC. The monoisotopic molecular mass of the toxic substance was 1197 Da, 
analyzed by RP-HPLC-MS. Amino acids were found after acid hydrolysis of the 1197-Da 
substance, using GC-MS analysis. The 1197-Da substance was toxic to fungi, boar sperm 
cells, feline fetal lung cells, and human neural cells. BLM analysis showed that the 
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substance formed channels conductive for potassium, sodium, and calcium ions. The same 
strains of B. amyloliquefaciens also produced another toxic substance. It damaged the boar 
sperm cell membrane and was identified as the lipopeptide surfactin, using commercial 
surfactin as a reference and the data of the RP-HPLC-MS/MS spectrum. The amino acids 
of surfactin were analyzed, as mentioned above. The structure and toxic effects of 
surfactin resemble those of lichenysin A (III). Bacillus amyloliquefaciens strain 19B also 
produced the fungicidal fengycin A and B, identified by MS and MS/MS analysis. 
V. The novel toxic 1197-Da substance from B. amyloliquefaciens was named amylosin. 
An RP-HPLC-UV quantitation method for amylosin was developed, using commercially 
available amphotericin B as the reference compound. The method is based on the precisely 
determined concentration of purified amylosin by 1H-NMR, using the ERETIC method. 
The amylosin chromophore possesses a polyene structure, as determined with NMR. 
Amylosin generates Na+- and K+-permeant channels as shown with BLM. A detailed 
study of the eukaryotic membrane-affecting properties of amylosin was executed, using 
isolated RLM. We proposed that the cytotoxicity of amylosin to sperm cells and feline 
fetal lung cells is due to its channel forming properties. This conclusion was supported by 
the results of its effects on the plasma transmembrane electric potential effect of 
mitochondria and plasma membranes of boar sperm cells. 
The Bacillus toxins and their main toxicity properties studied (I-V) are shown in Table 7. 
Table 7. Mode of actions and toxicity thresholds of Bacillus toxins studied (I-V). 
Compound Mol. mass 
Da
Mode of action Toxicity threshold to 
mammalian cells 
Cereulide 1152 Ionophore 
carrier for K+
0.5 nM 
Amylosin 1197 Ionophore 





Damaged cell membrane 4-8 µM 
Lichenysin A 1034 
 (major) 
Damaged cell membrane 4-8 µM 
5.2. Remarks 
Our results showed that Bacillus strains isolated from indoor air and food produced four 
different thermally stable peptides toxic to mammalian cells. One is a potassium 
ionophore carrier (cereulide), the second a novel potassium channel-forming peptide 
(amylosin) which was purified and its structure partially characterized, while the third 
(surfactin) and the fourth (lichenysin A) are membrane-disrupting and potential channel- 
forming lipopeptides. The antifungal lipopeptide (fengycin) was also found. Frequent 
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exposure to or ingestion of such compounds produced by Bacillus may represent a serious 
risk to health. Some strains producing lipopeptides are halotolerant up to a concentration 
of 16% NaCl and produce the lipopeptides in environments with up to 8% salt 
concentration (Roongsawang et al. 2002), indicating that such strains have the ability to 
grow and form toxins in salt-preserved food.
Cereulide is not commercially available. Therefore, in the present study we quantified 
cereulide using valinomycin (commercially available), which highly resembles cereulide, 
as the standard. Cereulide and valinomycin have identical UV-absorbing chromophores, 
ester, and amide bonds (see Fig. 7) in the UV range 200-220 nm. However, we cannot 
exclude the possibility that the molar extinction coefficient values of valinomycin and 
cereulide may differ, causing small errors in quantitation of cereulide in RP-HPLC-UV.
Valinomycin and cereulide can also act differently in the ESI technique used in RP-
HPLC-ESI-MS analysis to quantify cereulide. In the MS the possible dissimilar properties 
of valinomycin and cereulide of complexing cations may cause inaccuracy in 
quantification of cereulide. The toxicity studies indicated that the potassium complex of 
cereulide was more stable that of valinomycin (Teplova et al. 2006).
In general surfactin is produced at high frequence by Bacillus species. The strains of B.
amyloliquefaciens studied here produced surfactin in high amounts (6% of dry weight) 
and coproduced a new fungicidal substance (amylosin) in amounts constituting 1% of dry 
weight (IV). Lichenysin A production by B. licheniformis was also relatively high. Thus, 
high concentrations of surfactin or lichenysin A could be attained in indoor materials 
contaminated with B. amyloliquefaciens strains producing surfactin or in food by 
lichenysin A-producing B. licheniformis strains. Bacillus amyloliquefaciens was 
previously reported to produce surfactin and to possess lytic effects on protozoa. Surfactin 
is a persistent, hydrophobic molecule and can contaminate lungs and other tissues when 
dust or aerosols are inhaled. Surfactin may also damage the eyes when exposed to dust 
containing it. The eyes are protected against mechanical injury by a film consisting of oil, 
water, and mucus; the biosurfactant surfactin can destroy this film.
Surfactin and lichenysin A are able to bind the divalent ions of calcium and magnesium to 
form a more hydrophobic complex. Lichenysin A makes a 2:1 and surfactin a 1:1 complex 
with calcium; this may indicate that surfactin and lichenysin A can bind cadmium as well. 
Cadmium is toxic to mitochondria (Pathak and Khandelwal 2006) and surfactin or 
lichenysin A are potentially able to form hydrophobic complexes with cadmium and 
increase cadmium concentration in cells.
The toxicity threshold of amylosin for inhibiting boar sperm motility was 30 nM (V), thus 
15 and 60 times higher than that observed for valinomycin (2 nM) and for cereulide (0.5 
nM) (I), respectively. Amylosin depolarized the plasma membrane of boar sperm cells 
(IV, V), whereas cereulide and valinomycin had no effect (Hoornstra et al. 2003). 
Exposure to amylosin caused dysfunction in all studied cells: boar sperm, neural, and 
feline fetal lung cells. The toxicity of amylosin was explained by its channel-forming 
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properties found with BLM. Isolated RLM were used to show how amylosin forms 
independent potassium channels with no association with the mitochondrial ATP-
regulated K+ channel. One possible target of amylosin may be the central nervous system. 
Amylosin has the potential to disturb the signal system of neurons by forming sodium 
channels, as shown in BLM. Amylosin also forms calcium channels and can disturb 
calcium transport in cells. Calcium modulates many processes such as neurotransmission, 
enzyme, and hormone secretion, as well as many biological processes, e.g. cell cycle 
regulation and programmed cell death (Belkacemi et al. 2005)
Bacillus amyloliquefaciens strain 19B, found in indoor air, also produced fengycin in 
addition to amylosin and surfactin. There is an interesting relationship between fengycin 
and the pulmonary surfactant protein that aids the lung in breathing and contains the lipid 
dipalmitoylphosphatidylcholin (DPPC) (Yu and Possmayer 2003). Fengycin disturbs the 
organization of the DPPC monolayers in a concentration-dependent manner (Deleu et al. 
2005). The pulmonary surfactant protein contains DPPC and forms surface-active films on 
the alveolar surfaces. Fengycin may thus impair the function of the pulmonary surfactant 
essential for breathing.
Similar toxins were found from Bacillus strains isolated from moisture-damaged buildings 
and cases of food poisoning. Such occurrence is also common for toxin-producing fungi 
(see Chapters 1.1. and 1.2.). The structurally highly similar lichenysin A and surfactin 
were produced by Bacillus isolated from food poisoning and indoor environments, 
respectively. Cereulide was produced by B. cereus strains isolated from food poisoning 
(I). Cereulide-producing B. cereus strains were also isolated from the construction 
materials of buildings (Mikkola et al. 1999), filler material from hospitals, and filler 
material and dust from private dwellings (Andersson et al. 2002).
The Streptomyces species, such as S. griseus, which produce valinomycin (Andersson et 
al. 1998) are not isolated from food; however, there is one report of valinomycin produced 
by Bacillus species (Wulff et al. 2002). Valinomycin is a heat-stable substance possessing 
toxicity toward mammalian cells similar to the toxicity shown by cereulide (I, II, 
Andersson et al. 1998, Paananen et al. 2000, Teplova et al. 2006) but provokes an emetic 
symptom in Suncus murinus at 60 times higher concentration than cereulide (Agata et al. 
1995). Shinagawa et al. (1995) estimated that oral administration of 70 μg of cereulide 
could provoke an emetic reaction in rhesus monkey. Jääskeläinen et al. (2003a) suggested 
that rhesus monkeys and humans are equally sensitive to cereulide and the amount of 
cereulide needed to provoke the emetic symptoms in humans by ingestion (60 kg) is 400-
500 μg. Assuming that valinomycin causes the emesis in rhesus monkeys and humans 
similar to that observed in Suncus murinus, 4.2 mg and 24-30 mg of valinomycin are 
required for emetic reaction in rhesus monkeys and humans, respectively. Thus, if heat-
stable valinomycin produced by Bacillus strains contaminates food, a high amount (20-30 
mg) of highly toxic valinomycin must be ingested before the body is alarmed by vomiting, 
compared with a dose 60 times smaller in cereulide. On the other hand, vomiting could be 
considered as a first toxic reaction (in which the body is alarmed) and effects on the 
organs as a secondary (serious) toxic reaction to cereulide (or valinomycin). Most 
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probably, valinomycin-producing Bacillus species could not produce enough valinomycin 
in contaminated food to provoke vomiting. However, secondary serious intoxication could 
be caused by valinomycin before the body is alarmed by the vomiting. In the food 
poisoning cases, involving the B. cereus strains that produce cereulide, fatal dysfunctions 
of the liver were reported (Mahler et al. 1997, Dierick et al. 2005) and valinomycin 
definitely has the potential to provoke toxic effects similar to those of cereulide. 
Therefore, the potential of Bacillus species to produce valinomycin (or valinomycin 
analogues) should be monitored and studied in more detail.
Since some B. cereus strains that produce enterotoxins or cereulide can grow even at 
refrigerated temperatures, it is advisable to store leftover portions of cooked rice, pasta, or 
milk-containing foods in the freezer. In addition, the labels of many milk products, at least 
in Finland recommend storage temperatures of 0-8 °C. Many studies have shown that B.
cereus spores can survive pasteurization and 10% of the non-emetic or non-diarrheal 
strains of B. cereus have a minimum growing temperature of 4 °C, whereas for 50% of the 
diarrheal strains it is 7 °C (Pielaat et al. 2005, Carlin et al. 2006). These facts suggest that 
to prevent B. cereus from growing, the recommended storage temperature of industrial 
milk products and convenience foods should be 0-4 °C instead of the more commonly 
used 0-8 °C to improve food safety.
Due to the value of Bacillus species in industrial fermentations on one hand and their 
ability to form toxic compounds on the other, it is necessary to explore their non-toxicity 
before use as production organisms for large-scale biotechnical applications. This 
especially concerns genetically modified strains. Our results illustrate and reinforce the 
need to detect and identify toxic Bacillus non-protein metabolites. We therefore suggest 
that appropriate analytical HPLC-ESI-MS methods be developed and that an ESI-MS 
library of the known Bacillus toxins be created to accomplish this task. 
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Tiivistelmä
Tämän väitöskirjan aiheena on sisäilmasta ja ruoka-aineista eristettyjen itiöitä 
muodostavien Basillusten tuottamien lämmönkestävien toksisten ei-proteiini yhdisteiden 
rakenne ja toksisuus nisäkäs soluille Basillusten erittämien toksisten ei-proteiini 
yhdisteiden esiintymisestä, vaikutuksista ja kulkeutumistavoista kosteusvaurioisten 
rakennusten sisäilmassa ei ole paljon tutkimustietoa. Basillukset muodostavat ilmassa 
liikkuvia itiöitä, jotka voivat toimia toksiinien kantajina, kuten sisäilmasta eristetyt 
toksisten sienien itiöt. Ruoka-aineissa Basillusten itiöt ovat ongelmana, koska ne kestävät 
ruuanvalmistuksessa käytettäviä lämpötiloja ja ovat valmiita lisääntymään ruoka-aineissa 
suotuisissa olosuhteissa. 
Basillusten toksiset yhdisteet löydettiin käyttäen toksisuus indikaattorina sian siittiöiden 
liikkuvuuden muutosta toksisen altistuksen johdosta. Yhdisteiden puhdistuksessa, 
detektoinnissa ja rakenteen analysoimisessa käytettiin kaasu- ja nestekromatografiaa, 
massaspektrometriaa ja ydinmagneettista resonanssispektroskopiaa. Yhdisteiden 
toksisuutta ja vaikutustapoja tutkittiin käyttäen sian siittiöitä, kissan keuhkosoluja, ihmisen 
hermosoluja ja rotan maksasta eristettyjä mitokondrioita sekä BLM:ää (Black lipid 
membrane) ioniforisten ominaisuuksien selvittämiseen. 
Tämän väitöskirjatyön tuloksena löydettiin uusi K+ > Na+ > Ca2+ ionikanavan muodostava 
toksiini joka sai nimen amylosiini. Amylosiinia tuottivat kosteusvaurioisen rakennuksen 
sisäilmasta eristetyt B. amyloliquefaciens kannat. Amylosiini puhdistettiin 
nestekromatografilla ja monoisotooppinen atomipaino 1197 Da selvitettiin 
sähkösumutusionisaatio ioniloukku massaspektrillä. Lisäksi sen todettiin olevan peptidi 
happohydrolyysin ja aminohappojen kaasukromatografisen massaspektrometri analyysin 
avulla. Sen rakenteen todettiin sisältävän kromoforisen polyeeni ryhmän käyttämällä 
ydinmagneettista resonanssispektroskopiaa. Amylosiinille kehitettiin nestekromatogra-
finen kvantitointimenetelmä käyttäen makrolaktoni polyeenia amphoterisin B:tä 
(moolimassa 924 g/mol) referenssiaineena. 
Ruoka-aine myrkytyksestä eristetty B. licheniformis kanta tuotti solukalvoa rikkovaa 
lipopeptidiä, likenysiini A:ta, joka puhdistettiin nestekromatografilla. Likenysiini A 
identifioitiin matriisiavusteisella laserionisaatio lentoaika-massaspektrometrillä sen 
tuottamien protonoituneiden sekä kationioituneiden ammonium, natrium, kalium 
molekyylien avulla. Sen tuottamat protonoidut molekyylit olivat m/z 1007, 1021 ja 1035. 
Likenysiini A:n aminohapot analysoitiin sähkösumutus-ionisaatio kolmoiskvadrupolin 
massaspektrometrin tuottaman tandem-massaspektrin sekä lipopeptidin happohydrolyysin 
ja aminohappojen nestekromatografisen analyysin avulla. Sisäilmasta eristetyn B.
amyloliquefaciens kannan havaittiin tuottavan amylosiinin lisäksi lipopeptideja: sienille 
toksista fengysiinia ja solukalvoa hajottavaa surfaktiinia. Ne identifioitiin 
sähkösumutusionisaatio ioniloukku massaspektrillä niiden tuottamien protonoituneiden ja 
kationisoituneiden ammonium, natrium, kalium molekyylien sekä analysoimalla niiden 
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tuottamat tandem massaspektrit. Surfaktiinin tuottamat protonoidut molekyylit olivat m/z
1009, 1023 ja 1037 ja fengysiinin m/z 1450, 1463, 1493 ja 1506.
Kereulidi (moolimassa 1152 g/mol) puhdistettiin nestekromatografisesti ruokamyrkytys 
tapaukseen liittyvästä B. cereus kannasta. Kereulidi identifioitiin sen 
sähkösumutusionisaatio kolmoiskvadrupoli massaspektrometrin tuottamien protonoidun 
molekyylin m/z 1154, ammonium m/z 1171, natrium m/z 1176 ja kalium m/z 1192 
kationisoituneiden molekyylien avulla sekä tulkitsemalla kereulidin protonoidun 
molekyylin m/z 1154 tandem-massaspektrin tuote-ionit. Kereulidille kehitettiin 
nestekromatografinen kvantitointimenetelmä käyttäen sitä muistuttavaa valinomysiinia 
(moolimassa 1110 g/mol) referenssiaineena. Lisäksi osoitettiin empiirisesti, käyttämällä 
BLM:ää, että B. cereuksen tuottama emeettinen toksiini, kereulidi on tehokas ja spesifinen 
kalium ionifori, jonka toksinen vaikutus kohdistuu erityisesti mitokondrioiden toimintaan.
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